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Malaria is the one of most important diseases in the world, especially in sub-Sahara Africa.
This dissertation outlines the enormous burden of the disease in terms of social and economic
costs in southern Africa.
This dissertation assessed the range and quality of the cost-effectiveness of malaria prevention
in sub-Sahara Africa. Six studies published from 1999 to 2003 are reviewed, covering
insecticide treated nets, residual spraying, chemoprophylaxis for infants and environmental
management. For infants, ITNs cost from US$ 2019 - $2879 per death averted and cost $ III
per DALY; chemoprophylaxis cost $ 4.1 per DALY and chemoprophylaxis plus iron cost $
5.0 per DALY. For children, ITNs cost $ 1559 per death averted, $ 57 per DALY and $ 61
per sick child averted. For non-specific age group, ITNs cost $ 29 per infection averted, and
RHS $ 9.
Generally all interventions assessed are cost effective use of resources. The chemoprophylaxis
is the least expensive malaria prevention among cost effective malaria prevention
interventions, followed by residual spraying one round a year, residual spraying two rounds a
year, insecticide treated nets with net treatment only and insecticide treated nets with net
provision and treatment.
There are operational, managerial and financial challenges faced these most cost-effective
malaria interventions. Particularly, chemoprophylaxis is faced the tremendous drug resistance
potential and is not being recommended to wide use; financial constraints and the potential
delaying of children's immunity acquisition lowers the cost-effectiveness of insecticide
treated nets; residual spraying is a relatively simpler, faster and cheaper method, but faces
political and economic pressure of concerning environmental issues, especially the use of
DDT.
The integrated approach of environmental management plus residual spraying could be the
most cost-effective method of malaria prevention with least adverse environment effects.
However, policy makers should apply their knowledge to local conditions. Further,
comprehensive education programmes are needed to gain support and understanding from
local communities. This would raise the cost-effectiveness of all interventions.
Acknowledgements
My grateful thanks are due to my supervisor Professor Geoff Harris at the Department of
Economics and Management, whose interest in cost-effectiveness analysis for major public
health problems and encouragement let to my choice of the topic. I am also grateful for his
invaluable direction and patient help.
My indebted thanks are due to my friends for their support and encouragement, in particular, I
want to thank my friend Ms Greertje-Kieke Grootenhuis for her critical comments to my draft
and valuable discussions of environmental issues on some malaria interventions.
My sincere thanks are also due to my beloved mum Shujun, husband Ming, and son Yang for
their unending patience and support.
Finally, my most grateful thanks to the God, the Higher Power and the Universe for the






Chapter 1 Introduction 1
1.1 Background 1
1.2 Overall objective and specific aims 3
1.3 Overview 4
Chapter 2 The Malaria Problem in Southern Africa 5
2.1 Malaria and its epidemiology 5
2.1.1 Malaria's affects on children 5
2.1.2 Malaria's affects on pregnant women 6
2.1.3 Malaria transmission 8
2.2 Malaria in southern Africa 10
2.2.1 Malaria transmission in southern Africa 10
2.2.2 Burden of malaria on health in southern Africa 12
2.2.3 Malaria and poverty in southern Africa 14
2.2.4 Malaria burden on health expenditure in southern Africa 15
2.2.5 Malaria burden on economic productivity in southern Africa 15
2.2.6 Recent trends in malaria in southern Africa 16
2.3 Malaria eradication programme and malaria control: a briefhistory 17
2.4 Malaria control in southern Africa 20
2.4.1 Malaria control methods 21
2.4.2 Malaria control strategy 22
Chapter 3 An Overview of Cost-Effectiveness Analysis 24
3.1 Alternative evaluation methods 24
3.2 Cost-effectiveness analysis: the preferred method 28
3.3 The CEA procedure in summary 29
3.4 CEA applied to health programmes: some examples 30
3.5 Some limitations of CEA 30
3.6 Differences between evaluation studies 31
Chapter 4 A Review of Cost-Effectiveness Analyses of Malaria 33
Prevention
4.1 Identification of studies for review 33
4.2 Insecticide-treated nets 34
4.2.1 Differences in study settings and assumptions 36
4.2.2 Differences in results settings and outcome measures 36
4.2.3 Adjusted comparable outcomes 37
4.2.4 Cost-effectiveness ofITNs 37
4.3 Residual spraying 44
4.4 Chemoprophylaxis for infants 46
4.5 Environmental management for malaria control 48
Chapter 5 CEA Studies of Malaria Prevention and Malaria Control 55
5.1 CEA of malaria prevention 55
5.1.1 Results and their comparability 55
5.1.2 CEAs of malaria prevention in sub-Sahara Africa before 1998 57
5.1.3 Cost-effectiveness date and public health policy 60
5.2 Malaria prevention interventions 62
5.2.1 Malaria chemoprophylaxis 62
5.2.2 Insecticide treated nets 62
5.2.3 Residual House Spraying 64
5.2.4 DDT 65
5.2.5 Environmental management 67
5.3 Choice 68
Chapter 6 Conclusion 70
6.1 Introduction 70
6.2 An overview of results
Appendix Tables
Appendix 1 Kenya 1 gross outcomes (US$) - recalculation from the
initial data
Appendix 2 Kenya 1 gross outcomes with retreatment once a year
Appendix 3 Cost-effectiveness ratios of KINET for infants (US$ in
2000 price)
Appendix 4 ITN retreatment rate of Tanzania study
Appendix 5 Gross cost-effectiveness ratios of chemoprophylaxis and




2.1 Malaria kills children in three different ways
2.2 Malaria during pregnancy
2.3 Estimated malaria parasite prevalence ratios for children aged 2-9
years in southern Africa







2.1 Malaria country profile in southern Africa
2.2 Differences between malaria control and eradication
2.3 Classification of malaria control measures
3.1 CMA, CUA and CEA comparison and the nature of economic evaluation
of malaria preventive programmes
3.2 CBA and CEAJCUA comparison
4.1 Summary of cost-effectiveness analyses of malaria prevention in sub-
Saharan Africa
4.2 Base-case settings and assumptions
4.3 Gross cost-effectiveness results for interventions using comparable
outcome measures
5.1 The ranges of cost-effectiveness ratios of malaria prevention covered by
the current review, and earlier studies ($US)







































disability adjusted life year
dichlorophenyltrichloroethane
discounted life year gain
environmental management














Malaria is a public health problem in more than 90 countries, inhabited by a total of
some 2.4 billion people, representing about 40% of the world's population (WHO,
1998). Best estimates currently describe the annual global burden of malaria as 1.1
million deaths, 300-500 million cases, 44 million disability adjusted life years
(DALYs) (www.who.int/tdr/diseases/malari~. It has been estimated that the
economic burden is also extremely high, accounting for a reduction of 1.3 percentage
points in the annual economic growth rate of malaria endemic countries and that the
long term impact of this is a reduction of gross national production (GNP) by more
than half (Sachs and Malaney, 2002).
Over 90% of the disease burden is in sub-Sahara Africa, and almost all deaths due to
plasmodium fa1ciparum (one of four types of human malaria), occur in Africa, south
of the Sahara (www.who.int/tdr/diseases/malaria/), where malaria also presents major
obstacles to social and economic development. Malaria has been estimated to cost
Africa more than US$ 12 billion every year in lost GDP
(http://www.rbm.who.int/cmc_upload/O/OOO/O16/370/RBMlnfosheet_3.htrn).
The malaria burden differs according to age and gender. Almost all deaths occur in
African children under 5-years-old. Older Africans have reduced risk due to an ability
to develop a degree of immunity to the disease as a result of continuous exposure.
Outside Africa, where continuous exposure does not occur, the disease burden extends
into adulthood. Pregnant women in Africa (especially primigravidae) are at high risk
and are the major adult risk group in Africa. The malaria burden associated with
pregnancy has an additional impact due to the effect on the health of the foetus
(www.who.int/tdr/diseases/malariaD·
Areas on the northern and southern fringes of the malaria-endemic belt of Africa, as
well as highland ar,eas in many countries, are at risk of epidemic malaria. Unlike the
endemic disease, epidemic malaria affects people of all ages and can have high case-
fatality. Malaria also poses a risk to travellers and immigrants, with imported cases
increasing in non-endemic areas (www.who.int/tdr/diseases/malariaO·
Major trends over the last few decades point to a worsening situation making effective
action essential. These major trends include an increase in epidemic malaria; upward
trends in mortality over the last three decades, including in sub-Sahara Africa; an
upward trend in drug-resistant for p. falciparum malaria; the re-emerging ofp. vivax
malaria in areas from where it had been previously eradicated e.g. Caucuses and
Central Asia; and an increase in imported malaria in the developed world
(www.who.int/tdr/diseases/malaria/).
Thirty years after the abandonment of the first 'global' campaign to eradicate malaria,
the disease is again high on the international health agenda. In 1998, Roll Back
Malaria (RBM) was found as a global partnership by the World Health Organization
(WHO), the United Nations Development Programme (UNDP), the United Nations
Children's Fund (UNICEF) and the World Bank with the goal of halving the world's
malaria burden by 2010. The RBM partnership includes national governments, civil
society and non-governmental organizations, research institutions, professional
associations, UN and development agencies, development banks, the private sector
and the media (http://mosquito.who.int/cgi-
bin/rbm!dhomeJbm.jsp?ts=3238061358&service=rbm&com=gen&lang=en&type=in
tro&channelId=-8254&chLevel=2&p=rbminitiative).
RBM suggests a number of evidence-based, cost-effective interventions, which if
brought to scale in malaria-endemic countries, could have a significant impact on both
the morbidity and mortality of malaria. These suggestions include:
.:. Early diagnosis and prompt effective treatment of malaria
.:. Prevention of malaria through use of insecticide-treated materials and other
vector control measures including residual indoor spraying, larviciding and
environmental management
.:. Early detection and prevention of epidemics, and rapid response to epidemics,
through monitoring, surveillance, preparedness, timely action.
•:. Development of new tools, strategies and methodologies, together with the
improvement in delivery of existing tools through research and development
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·:. Coordinated action through establishing partnerships that utilize an optimal
•mix of measures adapted to local situations
(www.who. intltdr/diseases/malaria).
However, health policy-makers cannot decide on whether an intervention or
programme is worth supporting unless they have information on not only its
effectiveness but also its costs. Economic evaluation could make a substantial
contribution to malaria control decision-making. Given that malaria imposes an
economic burden on individuals and governments, disease reduction can therefore
produce savings in resources. Since resources are scarce, putting money into one
activity is always at the expense of not doing something else. Therefore, simply
knowing that there is an intervention that works is not sufficient to decide to spend
money on it. Policy-makers must compare the costs and effectiveness of the
intervention, with the costs and effects of additional investment in other services.
The research on the costs of an intervention is as important as research on its
effectiveness. Cost-effectiveness analysis could provide the information that is needed
by health policy-makers for decision-making. Costs are divided by health effects to
obtain a cost per unit of health effect, known as the cost-effectiveness ratio (Mills,
http://mim.nih.gov/englishlachievements/mim_conference-O5.pdf).
1.2 Overall Objective And Specific Aims
This dissertation overall objective is to review cost-effectiveness analyses of
malaria prevention published from 1999 up to the middle of 2003, in the African
context. The specific aims are:
.:. To outline the extent of malaria in suthern Africa, its social and economic
costs, to list the alternative preventive measures and current malaria control
strategy
.:. To explain cost-effectiveness analysis (CEA) as a method of deciding between
alternative means of preventing malaria
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.:. To review a large number of studies of preventive method to deal with
malaria, using a CEA framework, in order to show what methods are most cost
effective
Studies of cost-effectiveness analyses before 1999 have been reviewed by Goodman
et a1 (1999a), so this dissertation focuses on subsequent studies. Early studies of the
cost-effectiveness of malaria control were made by Barlow and Grobar (1986) and
Mills (1987).
1.3 Overview
.:. Chapter 2 will outline the extent of malaria in southern Africa, and its social
and economic costs; list the alternative preventive means and describe current
control strategy. It will then compare the malaria eradication programme with
the current malaria control strategy.
•:. Chapter 3 will explain CEA as a method of deciding between alternative
means of preventing malaria.
•:. In chapter 4, CEAs of malaria prevention published from 1999 up to middle
2003 in African context will be reviewed.
•:. In chapter 5, the comprehensive discussions on application complexity of both
cost-effectiveness analyses on the subject and malaria prevention interventions
will be presented.
•:. Chapter 6 will be the conclusion of the study.
4
CHAPTER 2 THE MALARIA PROBLEM IN
SOUTHERN AFRICA
2.1 Malaria And its Epidemiology
Malaria affects the lives of almost all people living in the area of Africa defined by
the southern fringes of the Sahara Desert in the north, and latitude of about 28 degree
in the south. Most people at risk of the disease live in areas of relatively stable malaria
transmission - infection is common and occurs with sufficient frequency that some
level of immunity develops. A smaller proportion of people live in areas where risk of
more seasonal and less predictable, because of either altitude or rainfall patterns.
People living in the peripheral areas north or south of the main endemic area or
bordering highland areas are vulnerable highly seasonal transmission and to malaria
epidemics (WHOIUNICEF, 2003, p17).
In areas of stable malaria transmission, very young children and pregnant women are
the population groups at highest risk for malaria morbidity and mortality. Most
children experience their first malaria infections during the first year or two of life,
when they have not yet acquired adequate clinical immunity - which makes these
early years particularly dangerous. Ninety percent of all malaria deaths in Africa
occur in young children. Older Africans have reduced risk due to an ability to develop
a degree of immunity to the disease as a result of continuous exposure. Adult women
in areas of stable transmission have a high level of immunity, but this is impaired
especially in the first pregnancy, with the result that risk of infection increases. The
malaria burden associated with pregnancy has an additional impact due to the effect
on the health of the foetus (WHOIUNICEF, 2003, p17).
2.1.1 Malaria's affects on children
There are three principal ways in which malaria can contribute to death in young
children (Figure 2.1). First, an overwhelming acute infection, which frequently
presents as seizures or coma (cerebral malaria), may kill a child directly and quickly.
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Second, repeated malaria infections contribute to the development of severe anaemia,
which substantially increases the risk death. Third, low birth weight - frequently the
consequence of malaria infection in pregnant women - is the major risk factor for
death in the first month of life. In addition, repeated malaria infections make young
children more susceptible to other common childhood illnesses, such as diarrhoea and
respiratory infections, and thus contribute indirectly to mortality (WHO/UNICEF,
2003).
Children who survive malaria may suffer long-term consequences of the infection.
Repeated episodes of fever and illness reduce appetite and restrict play, social
interaction, and educational opportunities, thereby contributing to poor development.
An estimated 2% of children who recover from malaria infections affecting the brain
(cerebral malaria) suffer from learning impairments and disabilities due to brain
damage, including epilepsy and spasticity (WHO/UNICEF, 2003, pI8). The malaria
burden associated with pregnancy has an additional impact due to the effect on the
health of the foetus












Source: WHO/UNICEF, 2003, pl8
2.1.2 Malaria's affects on pregnant women
Malaria infection during pregnancy is a major public health problem in tropical and
subtropical regions throughout the world. In most endemic areas of Africa, pregnant
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women are the main adult risk group for malaria. The main burden of malaria
infection during pregnancy results from infection with Plasmodium falciparum. Every
year at least 30 million women in malarious areas of Africa become pregnant; most of
these women live in areas of relatively stable malaria transmission (WHOIUNICEF,
2003, p38).
The symptoms and complications of malaria during pregnancy differ with the
intensity of malaria transmission and thus with the level of immunity acquired by the
pregnant woman (WHO, 2003). Since malaria transmission intensity may vary within
the same country from areas of relatively stable transmission to areas of unstable or
epidemic transmission, the clinical picture of malaria infection during pregnancy may
likewise range from asymptomatic to severe, life-threatening illness (WHO/UNICEF,
2003, p38).
In areas of epidemic or low (unstable) malaria transmission, adult women have not
acquire any significant level of immunity and usually become ill when infected with
p. falciparum. For pregnant women in these areas the risk of developing severe
malaria is 2-3 times higher than that for non-pregnant women living in the same area.
Maternal death may result either directly from severe malaria or indirectly from
malaria -related severe anaemia. In addition, malaria may result in a range of adverse
pregnancy outcomes, including low birth weight, spontaneous abortion, and neonatal
death (Figure 2.2) (WHOIUNICEF, 2003).
In areas of high and moderate (stable) malaria transmission, most adult women have
developed sufficient immunity that, even during pregnancy, p. falciparum infection
does not usually result in fever or other clinical symptoms. In these areas, the
principal impact of malaria infection is malaria-related anaemia in the mother and the
presence of parasites in the placenta. The resulting impairment of fatal nutrition
contributes to low birth weight and is a leading cause of poorer infant survival and
development (WHOIUNICEF, 2003).
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Figure 2.2 Malaria during pregnancy
In areas of low or
epidemic transmission
In areas of high or moderate
(stable) transmission
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Source: WHO/UNICEF, 2003, p38
2.1.3 Malaria's transmission
The intensity of malaria transmission varies considerably and includes malaria-free
areas as well as unstable and stable transmission areas. In unstable transmission areas
malaria is highly seasonal and occurs for only part of the year (usually less than 6
months). These areas are prone to epidemics which can result in high levels of
morbidity and mortality if not prevented or contained. There are several definitions:
on malaria transmission (http://www.malaria.org.zw/definitions.html):
Endemic malaria
Low endemicity: a person may attain adolescence (10 years of age) or even
adulthood (20 years) before infection is acquired.
Moderate endemicity: maximum incidence occurs in childhood and adolescence. But
it is not unusual for adulthood to be attained before acquiring infection.
High endemicity: by late infancy (6- 11 months) or early childhood (1- 4 years)
practically all are infected, little acute illness in adolescents and still less in adults.
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Hyperendemicity: most individuals acquire infection in late infancy or the second year
of life. Acute manifestations are less frequent on children over five years and unusual
in adults.
Malaria epidemic
Malaria epidemic is the occurrence of malaria cases in excess of the number expected
in a given place at a given time. This unexpected increase may therefore be
superimposed on the expected seasonal variations.
Seasonal malaria cycles
These are fluctuations in occurrence of malaria by season. The season is usually
determined by rainfall in tropical areas and by temperatures in sub-tropical and
temperate areas.
Periodic malaria cycles
These are cycles that usually last between 8 and 10 years. They are usually
determined by rainfall with amplified loss of immunity occurring in periods of low
rainfall and, hence, low transmission.
Secular trends of malaria
Long term upward or downward trends in occurrence of malaria.
Stable malaria
High transmission with very little variation between the years. Collective immunity in
the population is high. Epidemics are unlikely.
Unstable malaria
Transmission levels are low and vary from year to year. Collective immunity is low.
There is a high potential for epidemics.
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2.2 Malaria in Southern Africa
2.2.1 Malaria transmission in southern Africa
Southern African countries that have unstable transmission and are particularly prone
to malaria epidemics are Botswana, Namibia, South Africa, Swaziland and
Zimbabwe. In stable transmission areas malaria occurs throughout the whole year and
there is relatively little seasonal variation. Malaria morbidity and mortality is greatest
in these areas. Countries with predominantly stable transmission are Angola, Malawi,
Mozambique, Tanzania and Zambia. However, within these countries there are also
areas with unstable transmission that have a high risk of epidemics
(http://www.malaria.org.zw/malaria_burden.html).
In southern Africa, an arc can be drawn from South Africa in the south-east through
Botswana and to Namibia which shows the border between malaria-free areas and
unstable transmission areas. The Highveld of Zimbabwe and a few isolated upland
areas (>2000m), principally in Tanzania, are also malaria-free. The division between
unstable and stable transmission areas runs north along the South Africa-Mozambique
and Zimbabwe-Mozambique borders and then along the northern borders of
Zimbabwe, Botswana and Namibia. To the north of this line, there are also areas of
unstable transmission. Such as the Northern and Southern Highlands of Tanzania, and
large towns and cities (http://www.malaria.org.zw/s-profile.html).
The prevalence of malaria cases indicates the intensity of malaria transmission. High
levels of malaria prevalence (parasitaemia) in children indicate intense stable
transmission. In the map (Figure 2.3), it can see that in the stable transmission
countries, malaria prevalence among 2-9 years can be as high as 60%. While in the
unstable transmission countries, prevalence is considerably lower «15%). Vector
control in some of these countries (e.g. South Africa and Swaziland) has contributed
to bringing malaria prevalence down to very low levels «2%)
(http://v,rww.malaria.org.zw/malaria burden.htm I).
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Figure 2.3 Estimated malaria parasite prevalence rations for children aged 2-9






A number of factors affect malaria transmission in the subregion. The chief
determinant is climate which affects both the life of the anopheles mosquito and the
development of malaria parasites. The development of malaria parasites is great
retarded below 20 Celsius and ceases to develop below 16 Celsius. In addition,
relative humidity of over 60% lengthens the life of the mosquito enabling it to
transmit the infection (http://www.malaria.org.zw/s-.-profile.html).
There are also a number of human factors that affect malaria transmission. Vector
control efforts, particularly residual house spraying programme and source reduction
in urban areas have made previously malarious districts malaria-free. Equally the
breakdown of vector control has resulted in previously malaria-free areas such as the
Zambian Copperbelt becoming malarious again. Forced and voluntary population
movements affect malaria transmission, as do man-made changes to the environment.
For example, urbanisation leads to source reduction while dam building - particularly
is semi-arid areas - can create foci of malaria transmission
(http://www.malaria.org.zw/malaria_burden.html).
The movement of non-immunes to malarious areas (e.g. urban migrants visiting
families in rural areas, business travellers and tourists) can put individual at risk of
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severe malaria. Major population movements from low to high intensity transmission
areas triggered by such factors as resettlement schemes, natural disasters or conflict
can cause a sharp upturn in malaria incidence and sometimes lead to epidemics.
Migrants can introduce malaria (or drug resistant strains) into previously malaria-free
areas. Other ways migration can affect malaria transmission are by alter its
environmental conditions which facilitate or hinder transmission; and introducing new
ideas and malaria control products into rural communities
(http://www.malaria.org.zw/malaria_burden.html).
2.2.2 Burden of malaria on health in southern Africa
A summary of the extent of the malaria problem on health in southern Africa is as
follows: (http://www.malaria.org.zw/malaria_burden.html)•
•:. Malaria is the first or second leading cause of illness and death
.:. Malaria is responsible for 200,000 deaths per annum
.:. Between 10,000,000 and 37,000,000 confirmed cases of malaria occur per
annum
.:. The incidence of confirmed malaria is between 73 and 266 per 1000
population per annum
.:. The incidence of confirmed malaria ranges is between 115 and 420 per 1000
population at risk per annum
.:. Malaria parasitaemia among children age 2-11 years ranges from 0-5% to 40-
60%
.:. Malaria accounts for between 3 (Swaziland) and 50% (Malawi) of outpatient
attendances
.:. Malaria accounts for between 3% (Swaziland) and 24% (Malawi) inpatient
deaths
Malaria is a major cause of mortality in Southern Africa. Of the 139 million people
living in Southern Africa, approximately 63% live in malarious areas. In areas of
stable transmission, the most important risk groups are under-five year olds, pregnant
women and travellers who normally reside in unstable or malaria-free areas. In the
predominantly stable transmission countries - Angola, Malawi, Mozambique,
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Tanzania and Zambia - there are an estimated 13,678,000 under-five year olds and
3,302,000 pregnant women at risk of severe malaria. In the predominantly unstable
transmission countries - Botswana, Namibia, South Africa, Swaziland and Zimbabwe
- where all age groups have a high risk of malaria due to low levels of acquired
immunity, it is estimated 12,382,000 people are at risk of malaria
(http://www.malaria.org.zw/malariaburden.htm1)
Table 2.1 Malaria country profile in southern Africa
Population Under-five Pregnant Population People Under-5 Women at
year aids women living in living in year olds at risk of
malarious malarous risk of malaria
areas areas malaria
Angola 11967000 2297000 568000 lOO 11967000 2297000 568000
Botswana 1551000 243000 54000 40 6204000 97200 21600
Malawi 10377000 1933000 493000 100 10377000 1933000 493000
Mozambique 16118000 2836000 682000 100 16118000 2836000 682000
Namibia 1653000 261000 59000 66 1090980 172260 38940
S. Africa 44295000 5943000 1311000 10 4429500 594300 131100
Swaziland 931000 150000 34000 30 279300 45000 10200
Tanzania 32189000 5650000 1324000 90 28970100 5085000 1191600
Zambia 8690000 1536000 368000 100 869000 1536000 368000
Zimbabwe 11924000 1975000 438000 50 5962000 378500 219000
139695000 22824000 5331000 63 88504280 15583260 3723440
Source: http://www.malaria.org.zw/malaria_burden.html
The consequences of malaria in pregnancy include anaemia, miscarriages, stillbirths
and low birthweight. Cerebral malaria can lead to disabling neurological sequelea.
Hence, among young children, an episode of severe malaria may negatively impact on
their educational attainment. In stable transmission countries severe anaemia among
under-fives is more common than cerebral malaria. In unstable transmission countries,
cerebral malaria is the main complication of severe malaria
(http://www.malaria.org.zw/malaria_burden.html).
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2.2.3. Malaria and poverty in southern Africa
The health of a nation is of primary importance to social and economic development.
Within southern Africa, malaria is a major impediment to socio-economic
development and an important cause of poverty.
Poverty also affects malaria. Communities with low incomes, limited education and
poor access to health care are least able to engage in malaria control activities.
Prevention of malaria may not be affordable nor properly understood. Equally,
treatment-seeking behaviour may be influenced by lack of education as well as
inability to pay transport, consultation and treatment fees at health facilities. At the
same time, malaria affects poverty. In poor households, a greater proportion of
income is likely to be spent on malaria treatment than in richer households, malaria
illness can cause to absenteeism from work and school, poor scholastic performance,
lack of labour for cultivation, and a decline in child care; malaria deaths can lead to
funeral costs, loss of an income-earner and a rise in orphanhood. Hence, a negative
spiral can develop with malaria causing and deepening poverty which, in turn,
exacerbates inequalities in society. Malaria-poverty linkages may exist both in poor
rural communities as well a peri-urban settlements
(http://www.malaria.org.zw/malaria_burden.html).
Poor people are at increased risk both of becoming infected with malaria and of
becoming infected more frequently. Child mortality rates are known to be higher in
poorer households and malaria s responsible for a substantial proportion of these
deaths. Poor families live in dwellings that offer little protection against mosquitoes
and are also less likely to be able to pay either for effective malaria treatment or for
transportation to a health facility capable of treating the disease. Both direct and
indirect costs associated with a malaria episode represent a substantial burden on the
poorer households. A study in northern Ghana found that, while the cost of malaria
care was just 1% of the income of the rich, it was 34% of the income of poor
households. Moreover, in epidemic-prone countries, malaria epidemics are likely to
be most severe in the poorest communities
(http://www.malaria.org.zw/malaria_burden.html).
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2.2.4 Malaria burden on health expenditure in southern Africa
Within the Ministry of Health, malaria uses up resources for its prevention and
control. In addition, expenditure on insecticides, drugs, equipment etc. and large
numbers of malaria patients may lead to health facility staff being stretched beyond
capacity, thereby reducing the standard of care received by all patients. Malaria also
exerts a major burden on other Government ministries, notably education
(http://www.malaria.org.zw/economics.html).
Malaria is responsible for a high proportion of public health expenditure on curative
treatment, and substantial reductions in malaria incidence would free up available
health resources and facilities and health workers; time, to tackle other health
problems. (WHOIUNICEF, 2003)
2.2.5 Malaria's economic burden
Malaria impacts on the economy at a number of levels including within households
and communities, the private sector, government and the macro economy
(http://www.malaria.org.zw/economics.html).
Malaria in the household may lead to:
.:. Absenteeism from work or school
.:. Important domestic fobs such as cultivation of crops and water/food gathering
may be neglected
.:. Reduced household income
.:. Reduced household expenditure on food
.:. Increase in nutritional deficiencies
.:. Children taking off school to care for family or earn money
.:. Reduced expenditure on school fees
.:. Under performance at school and lack of achievement of personal potential
.:. Increased financial and time costs of attending health centres and buying drugs
.:. Increased numbers of orphans and foster children
.:. Long term losses in household productivity in the case of mortality
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.:. Funeral costs
Malaria affects the productivity of the private sector. Key businesses that are
particularly affected by malaria are likely to include agriculture, tourism, mining and
construction industries. The private business sector may be adversely affected by the
problems of a sick workforce. The level of productivity may decline (especially in
agriculture if an epidemic coincides with harvest or planting time) and the costs of
providing sick pay (if it is paid) will rise. The cost of private healthcare provided by
employers may also rise dramatically. In short, profits will be eroded.
A government is responsible for the health and wellbeing of its people, rising malaria
costs can have the following effects:
.:. Use up funds that could be employed in other important areas to benefit the
country
.:. Drain the health care resources
.:. Reduce revenue available to the government, e.g. sickness leads to lower
earnings and expenditure and thereby to lower tax revenues
.:. Place great pressure on health workers
.:. Reduce the standard of care to non-malaria patients
.:. Reduce private sector profits caused by declining productivity
Poverty and inequalities are exacerbated, government resources come under
increasing pressure, and the private sector faces reduced investment, growth, profits
and inflow of foreign currency. Together, this will result in a decline in gross
domestic product and socio-economic development being hindered.
2.2.6 Recent trends of malaria in southern Africa
Major trends over the last few decades point to a worsening situation if effective
action is not taken. These trends include: an increase in epidemic malaria; upward
trends in mortality over the last three decades, including in sub-Sahara Africa; an
upward trend in drug-resistant p. fa1ciparum malaria; the re-emerge of p. vivax
malaria in areas from where it had been previously eradicated e.g. Caucuses and
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Central Asia; and increase in imported malaria in the developed world
(www.who. intltdr/diseases/malarial).
In southern Africa, qualitative reports as well as surveillance data indicate that malaria
deaths are rising in some countries (Namibia, South Africa, Zimbabwe). Malaria
mortality in under-5s almost doubled in eastern and southern Africa over the period
1990-1998 compared with 1982-1989. It is likely to be due to a combination of factors
including late-treatment seeking behavior, quality of care, inadequate transport and
communication for referral systems to function properly, the improved coverage of
Health Information System (HIF) and misdiagnosis due to a general rise in fevers
associated with HIV. However, the main reasons for this are likely to include
deteriorating health sectors within the subregion, a breakdown in malaria control
efforts, rising drug and insecticide resistance, population movements and
environmental changes favouring malaria transmission. It is known that the
prevalence of malaria infections caused by chloroquine-resistant parasites increased
substantially from the late 1980s in these same areas. Thus, although the methodology
cannot prove cause and effect, it is very likely that some of this increase in child
mortality was related to some extent to the spread of chloroquine-resistant malaria
(http://www.malaria.org.zw/malaria_burden.html).
Consequently, within Southern Africa, there is need to increase investment in malaria
control as well as to understand, investigate and mitigate the relationships between
malaria and socio-economic development. Improvements in access to primary health
care and primary school enrolment in Southern Africa are likely to have increased the
ability of the poor to prevent and control malaria.
2.3 Malaria eradication and malaria control: a brief history
Soon after the Second World War the World Health Organization recognised that
malaria not only killed more people than any other disease but also interfered with the
development of agriculture and industry. The advent of DDT presented the world with
a new method of interrupting the transmission of malaria infection by attacking the
adult anopheles vector during its epidemiologically most important stage, when it
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feeds on man in his dwelling or when it shelters indoors in the nearest house or animal
shelter.
The worldwide programme of malaria eradication was formally endorsed by the
Eighth Would Health Assembly in 1955 and in 1957 the WHO took over the
coordinating activities and the provision of technical assistance. The malaria
eradication programme has been defined as an operation aimed at cessation of
transmission of malaria and elimination of the reservoir of infected cases in a
campaign limited in time and carried to such a degree of perfection that, when it
comes to an end, there is no resumption of transmission (Leonardo, 1980).
The global malaria eradication campaign had succeeded in increasing the population
freed from malaria transmission from 400 million to 1200 million. By the early 1970s
malaria had been eliminated from the whole of Europe, the Asian part of the USSR,
several countries of the Near East, most of North America including the whole USA,
most of the Caribbean, large areas of the northern and southern portions of South
America, Australia, Japan, Singapore, Korea, Taiwan and China (Leonardo, 1980).
However, many countries in Africa lacked the infrastructures and resources necessary
to mount sustainable campaigns against malaria and as a result few benefited from
historical efforts to eradicate malaria (http://
www.rbm.who.int/cme_upload/0/000/015/370/RBMlnfosheet_3.htrn).
After two decades of this unique international endeavour in the field of public health,
the overall results are of great interest; yet they show that under some conditions it
cannot be put into practice. Because of serious technical problems (multiple resistance
of vectors to insecticides and drugs to anopheles, exophilic behaviour of vectors, or
population migration), administrative limitations (in financial resources or
organisation structure), or the consequences of natural disasters (earthquakes,
cyclones, or floods), there is a need oflong-term malaria control programme that
reflect its very nature of flexibility, adaptation to variable epidemiological conditions,
dependence on social, administrative, and even political conditions (Leonardo, 1980).
The differences between malaria control and malaria eradication are given in Table
2.2.
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Table 2.2 Differences between malaria control and eradication
Control Eradication
Objective Reduction of incidence until Cessation of transmission
no longer a major public health and elimination of the
problem human reservoir of infection
Duration Indefinite Limited in time
Area of operation Only where transmission is All areas where transmission
intense occurs





Cost Recurring Capital investment; after
completion no recurring
annual cost except for
surveillance
Assessment of Sampling of population for Case detection (active and
results parasite rates and spleen rates passive) in advanced stages.
(malariometric surveys) Surveillance procedure
Imported cases Not relevant Of concern in advanced
stages of the programme
Source: Bruce-Chwatt, (1980, p281).
Thirty years after the abandonment of the first' global' campaign to eradicate malaria,
the disease is again high on the international health agenda. In 1992, malaria control
was re-established as a global health priority by a Conference of Ministers of Health
held in Amsterdam. In 1998, Roll Back Malaria (REM) was found as a global
partnership by the World Health Organization (WHO), the United Nations
Development Programme (UNDP), the United Nations Children's Fund (UNICEF)
and the World Bank with the goal of halving the world's malaria burden by 2010. The
REM partnership includes national governments, civil society and non-governmental
organizations, research institutions, professional associations, UN and development
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Tackling malaria effectively requires substantial resources. At the Roll Back Malaria
Abuja Summit in 2000, it was estimated that at least US$ 1 billion is needed from a
combination of increased domestic spending and international assistance. Since the
launch of RBM in 1998, international spending on malaria has more than doubled to
approximately US$ 200 million per year. However, the finance resources for fighting
malaria are increasing. The establishment of the Global Fund to Fight AIDS,
Tuberculosis and Malaria is providing significant new grants to help countries
accelerate implementation of their plans to Roll Back Malaria. In addition, funds
made available to improve health under debt-relief initiatives are being used to
finance malaria interventions in some countries. (WHOIUNICEF, 2003)
Southern African Malaria Control (SAMC) was set up in 1997, by the World Health
Organization, to spearhead the fight against malaria in Southern Africa (Angola,
Botswana, Malawi, Mozambique, Namibia, South Africa, Swaziland, Tanzania and
Zimbabwe) (http://www.malaria.org.zw/samc.html)
2.4 Malaria Control in Southern Africa
Southern Africa has a long history of malaria control going back over 50 years.
Malaria is accepted as national and regional public health priority in Southern Africa.
Today, Angola, Botswana, Malawi, Mozambique, Namibia, Swaziland, South Africa,
Tanzania, Zambia and Zimbabwe have established or are establishing malaria control
units and programmes a national levels. Small scattered malaria projects in different
areas are slowly being integrated and co-ordinated into national programmes to cover
all populations in malarious areas. However the priority tends to be higher in
countries such as Botswana, Namibia, Zimbabwe, South Africa and Swaziland where
unstable malaria with annual and cyclical epidemics caused alarm and crises.
Unfortunately malaria as a priority appears low in stable endemic countries (Zambia,
Malawi, Tanzania) where chronic malaria with a higher but less dramatic burden
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continues to be accepted as a problem to live and die with. In Angola, there are
conflicting priorities for basic survival following 35 years of armed conflict
(http://www.malaria.org.zw/public_mgt.html).
Success has been achieved in southern Africa in establishing malaria free areas and
reducing the level of infection and reducing deaths from malaria in some countries.
However, there is still a great challenge for national malaria control programs to
widen their activities and coverage on an annual basis for the next 10 - 20 years to
ensure that all people at risk of malaria have insecticide soaked bed nets or sprayed
homes, and can reach and be diagnosed and treated quickly for malaria with drugs in
the community, or at a health centre or hospital
(http://www.malaria.org.zw/public_mgt.html).
2.4.1 Malaria control methods
Malaria control methods vary from the simplest to the most elaborate but the success
of the former or the failure of the later are equally likely if they are applied without
careful consideration of the local problem to determine the best solution in the light of
available knowledge.
The classification of malaria control measures in relation to the chain of infection
includes those that aim at the prevention of the contact of man with the Anopheles
vectors or at the reduction of the vector population in its larval or adult form. Finally
chemotherapeutic means are designed to eliminate malaria parasites in the human
host. Most of these measures can be also considered from both the individual and
collective angles. Malaria control measures are summarized in Table 2.3.
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Table 2.3 Classification of malaria control measures
Type of measures Individual protection Community protection
Prevention of man! vector Repellents, protective Site selection, screening
contact clothing, bed- of houses
nets/insecticide-treated
nets, screening of houses
Vector Destruction Use of domestic space Space spraying, ultra low
control of adult sprays including aerosols volume sprays, residual
Anopheles insecticide spraying
vectors
Destruction Peri-domestic sanitation, Larviciding of water
of mosquito intermittent drying of surfaces, intermittent
larvae water containers drying, sluicing,
biological methods
Source Filling, small scale Prevention of man-made
reduction of drainage and other forms malaria, environmental




Measures against the Diagnosis and early home Diagnosis and early
malaria parasites treatment, treatment for outpatient





Social participation Motivation from personal Community involvement,
and family protection health education,
expansion of rural health
services. Training of staff
Source: Bruce-Chwatt (1980, p274)
2.4.2 Malaria control strategy
RBM suggests a number of evidence-based, cost-effective interventions which, if
brought to scale in malaria-endemic countries, could have a significant impact on both
morbidity and mortality from malaria. These are including:
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.:. Early diagnosis and prompt, effective treatment of malaria
.:. Prevention of malaria through use of insecticide-treated materials and other
vector control measures including residual indoor spraying, larviciding and
environmental management
.:. Early detection and prevention of epidemics, and rapid response to epidemics
(through monitoring, surveillance, preparedness, timely action).
•:. Development of new tools, strategies and methodologies, and improvement in
delivery of existing tools through research and development
.:. Coordinated action through establishing partnerships that utilize an optimal
mix of measures adapted to local situations
(www.who. int/tdr/diseases/malariaL)
In southern Africa, the national malaria units and programs have to struggle to
maintain a critical presence within changing and unstable health systems within the
current health reform and sector wide process. The critical issues being how to create
and maintain malaria as a priority health problem and ensure health policy support
and develop health systems and malaria control systems to rapidly scale up and
effectively and equitably deliver access, coverage, quality and impact with the
available malaria control tools (diagnostics, drugs, ITNs, house spraying) through a
health delivery system and to sustain continuing high levels of coverage.
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CHAPTER 3 AN OVERVIEW OF COST-
EFFECTIVENESS ANALYSIS
Economic evaluation could make substantial contribution to malaria control decision-
making. Disease gives rise to an economic burden on individuals and governments,
and disease reduction can therefore produce savings in resources. Since, resources are
scarce, putting money into one activity is always at the expense of not doing
something else, and as a result, simply knowing that we have an intervention that
works is not sufficient to decide to spend money on it, policy-makers must compare
the costs and effectiveness of the intervention, with the costs and effects of additional
investment in other services.
3.1 Alternative Evaluation Methods
The techniques ofeconomic evaluation are based on the economists' concern with
economic efficiency and opportunity costs and of an important contribution to the
methods of health service evaluation. Economic evaluation studies generally seek to
address the two questions: are limited resources used in the best ways possible? Is
value for money achieved in their use?
Economic evaluation has been defined as 'the quantitative analysis of the relative
desirability to the whole community of investing in alternative projects or
programmes', where desirability is assessed in terms of both costs and consequences
(Mills, 1988). 'Consequences' is used here as the generic term for the beneficial
results of a programme (often termed effects or benefits, depending on the techniques
of analysis being used). Within this broad definition there are many forms of
economic evaluation, as shown in Figure 3.1. Only those forms which examine both
costs and consequences for two or more alternatives fit the above definition and can
be described as full economic evaluation studies. In practice, one of the two
alternatives examined may be an existing project/programme (the 'do-nothing'
alternative).
24
Figure 3.1 Forms of economic evaluation













1. Cost minimization analysis
Yes
Effectiveness Cost analysis 2. Cost effectiveness analysis
evaluation
3. Cost benefit analysis
4. rost utility amJlysis
Source: Drummond et ai, 2001.
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Cost-minimisation analysis (CMA) (Mills, 1988) is based on prior epidemiological
findings which show that the outcome of interest (e.g. reduction of disability) is
achieved to the same degree by two (or more) interventions. The technique is used to
identify the least cost intervention.
Cost-effectiveness analysis (CEA) investigates the best way of achieving a single
objective by comparing effects and costs. It evaluates either:
.:. which of a number of possible interventions will achieve a given health
objective at least cost, or
.:. given a fixed budget, the intervention that maximises the effectiveness of the
expenditure.
Its results are expressed either as costs per unit of output (total costs of the
intervention divided by total health effect) or as effect per monetary unit (total health
effect divided by total available resources).
Cost-benefit analysis (CBA) (Mills, 1988) values both costs and benefits in monetary
terms, and compares them, assessing whether the project/programme is desirable
through the use of decision criteria (e.g. if the benefit cost ratio (benefits divided by
costs) is greater than one, the project/programme is worthwhile).
Cost-utility analysis (CUA) (Mills, 1988) is a form of CEA but it measures the effects
or a project/programme in terms of utilities (the quality-adjusted health outcome
caused or averted). Like CEA it can focus on either minimizing cost or maximizing
effects; and its results are expressed, for example, in terms of costs per Quality
Adjusted Life Year (QALY) or QALYs per monetary unit.
The root differences between these techniques concern their evaluation of health
outcome (consequence) and their breadth of analysis (dimensions of objectives). A
cost-minimization analysis can only be carried out without ambiguity if it based on
existing medical evidence of effectiveness. However, if the effectiveness evidence
were to be generated at the same time as the costs, one would not know in advance
whether equivalence in effects would be obtained. Therefore, the ex ante design for
these studies is usually CEA. On some occasions the study may require to assess
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multiple dimensions of effectiveness. And, normally CUA is more appropriated than
the others. The comparison of the differences among CMA, CEA, and CUA is
summarised in Table 3.1. The nature of economic evaluation of malaria preventive
programmes in terms of consequences and their breadth of analysis is also presented
in Table 3.1, and indicate that CEA is the best match.
Table 3.1 CMA, CUA and CEA comparison and the nature of economic
evaluation of malaria preventive programmes
Objectives Effectiveness
CMA Non-change effectiveness
CUA Multiple dimensions Effectiveness may change along with costs
CEA Single goal Effectiveness may change along with costs
Malaria Single goal Effectiveness may change along with costs
preventive
CBA is broader in scope than CEAlCUA given that CBA converts all costs and
benefits to money, it is not restricted to comparing programmes within health care, for
example, but can also be used to inform resource allocation decisions between sectors
of the economy (Drummond 2001). In contrast, CEAlCUA is necessarily restricted to
programmes that produce similar units of outcome such as DALYs. However, the
difficulties in assigning a monetary value to human life or quality of health outcome
make CBA cumbersome when applied to health care programmes. Therefore, the less
complex CE is preferred for health programme evaluations, in which the results are
explicitly stated in terms of health outcomes rather than money. The differences
between CBA and CEAlCUA are summarised in Table 3.2 below.
Table 3.2 CBA and CEA/CUA comparison
Objectives Costs measure Benefits measure
CBA Single dimension and multi- Monetary unit Monetary unit
dimensions
CEAlCUA CEA: single dimension Monetary unit Costs per unit




It is important to specify the form of evaluation and to outline an analysis plan in
advance, for which the following rules of thumb (Drummond et aI, 2001) should be of
some help:
.:. Take time to clarify the objectives of the programme or treatment.
.:. If one major dimension for the measurement of success is apparent, perform a
cost-effectiveness analysis based on this dimension (or perform a cost-
minimization analysis if it turns out that the alternatives have equivalent
effectiveness on the chosen dimension.)
.:. Look for other attributes of the alternatives being assessed, even if the medical
research design does not consider these formally. Where possible, record the
effectiveness of the alternatives as judged on these extra dimensions and be
prepared to mount ad hoc surveys to obtain more information
.:. Keep open the possibility of employing more sophisticated forms of analysis if
it turns out that there is more than one appropriate dimension for judging
effectiveness.
With respect to malaria preventive programmes, it is clear that the appropriate
economic evaluation technique is CEA. CEA is most useful when the interventions
being compared have a clear and specific outcome. CEA is most suited, then, to
scenarios such as
1. Comparing alternative strategies of an identical goal
2. Identifying which intervention method is best for a specific population
3. Providing empirical support for the adoption of previously underfunded
programs with low cost-effectiveness ratios
4. Identifying practices that are not worth their cost (Getzen, 1997)
The malaria preventive programmes mainly concern one clear objective - preventing
malaria occurrence - although there may have some other effects. Therefore cost-
effectiveness analysis is the appropriate method by which to evaluate alternative
malaria prevention programmes. Cost-utility analysis and cost-benefit analysis are too
complicated in the purpose of the programmes analysis.
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3.3 The CEA Procedure In Summary
The major steps of cost-effectiveness analysis are summarized as following (Shepard
and Thompson, 1979):
1. Define the programme
.:. Develop alternative approaches to problem
.:. Define precisely programmes to be analysed (who, what, where, why, when,
and how)
2. Compute net costs
.:. Compute gross programme costs
.:. Compute monetary savings
.:. Discount costs and savings to present value.
•:. Compute net costs (gross costs less savings)
3. Compute net health effects (in terms of additional years of healthy life)
.:. Add
~ Additional years with full health,
~ Additional years of disease,
~ Improvement in health (no extension of life),
~ Negative effects (inconveniences and morbidity)
.:. Modify by time preference factors
4. Apply decision rules
.:. Identify case based on signs of net costs and net effects
.:. Apply rule for appropriate case
5. Perform sensitivity analysis
.:. Vary uncertain parameters and recomputed costs and health effects.
•:. Examine effects on decision
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3.4 CEA Applied To Health Programmes: Some Examples
Cost-effectiveness analysis is a very useful approach where there is a single
unambiguous objective of health programmes. CEA is a common economic
evaluation tool in selection between prevention and treatment for infectious diseases.
With regard to HIV/AIDS, the common effectiveness of HIV/AIDS interventions,
whether the intervention is prevention, treatment or care, could be easily identified as
death averted, HIV infection averted or disability adjusted life year gained (Creese et
aI, 2002; Bos et aI, 2001). It's also common to see CEA used in health programme
selection for tuberculosis (Migliori, et aI, 1998), hepatitis (Zhou et aI, 2003; San et aI,
2003), and etc., with similar outcome measures of death averted, infection averted or
disability adjusted life year gained.
CEA is also often seen for selection of various interventions for cancer treatment
(e.g., Monz et aI, 2003; Ladabaum et aI, 2003; Mahadevia et aI, 2003). The outcome
measures usually identified as life year gained, discounted life year gained and quality
life year gained. It has been seen that antidepressant programme used CEA to
compute cost-effectiveness with outcome measure of cost every 10% chance of
response (Kim et aI, 2003), acute migraine treatment with cost per attack treated
(Wells et al,2003), schizophrenia and persistent auditory hallucinations with cost per
patient (Stant et aI, 2003) and various other diseases interventions, such as
pharmacotherapies for Parkinson's disease (Coyle et aI, 2003) and treatment for
osteoporosis (Johnell et aI, 2003), etc. Further, comparison of Hospital at Home and
in-patience interventions could use CEA framework with outcome measure of cost per
treatment day (Jester et aI, 2003).
3.5 Some Limitations Of CEA
With cost-effectiveness analysis, some limitations and difficulties of the method
should be noticed. The most salient practical problem in performing cost-effectiveness
analysis is the lack of adequate data. Definitive data on the likely health effects of
preventive programmes are rare, and cost data, too, are often insufficient. While this
problem complicates and reduces the precision of cost-effectiveness analysis, it may
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paradoxically increase the attractiveness of performing this analysis. Many important
decisions cannot wait until ideal data are obtained. Compared with alternative
processed for decision-making - for instance, cost-benefit analysis or intuition- cost-
effectiveness analysis is better able to cope with data problems because CEA avoids
the difficult problems of money valuation. Moreover, CEA provides a framework for
using the available objective data and the subjective estimates of experts.
Representative experts or consumers can be polled and ranges of values considered. A
weakness of cost-effectiveness analysis, therefore, is that it rarely yields a single,
definitive answer. Its partly compensating advantage is that assumptions are made
explicitly and their effect on the analytic results is made clear.
A related weakness is the practical difficulty of incorporating consumers' input into
an analysis. In theory, the method can incorporate the preferences of any
representative consumer in evaluating alternative programmes. Valuations of quality
of life can be made by past, current, or prospective recipients of a treatment. Because
these values are shown explicitly, the resulting analysis can be scrutinized to assure
that these preferences, and expert opinions, have been interpreted correctly. With a
sensitivity analysis, the opinions of many experts and the values of many consumers
can be incorporated. Undoubtedly, however, analysts wiII need patience and
sensitivity to elicit preferences that are expressed in a usable manner, and consumers
may require examples and nontechnical explanations before accepting any numerical
analysis.
3.6 Differences Between Evaluation Studies
This review aims to look at studies of cost-effectiveness analysis for malaria
prevention programmes. These studies have a common framework:
.:. Objectives: compares the effectiveness and cost-effectiveness of preventive
programmes against malaria infection in concern ofpopulations and/or highly
affected area
.:. Questions being answered: assess whether and in what circumstances costs are
associated with the better gain in outcome from malaria preventive alternatives;
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test the sensitivity of the results to the use of different means of the malaria
preventive programmes.
•:. Date analysis methods: normally are within cost-effectiveness analysis
framework, may associated with scientific statistic data analysis.
•:. Conclusion: provide guidelines for the provision of preventive services
The procedures may differ between studies. Different economists may use different
approaches in conducting cost-effectiveness analysis. For instance, Mills et al (1988)
suggest three basic steps, while Haddix et al (1996) suggest nine basic steps. Other
differences may include the following:
The way of settling direct costs and indirect costs - what is included, what is not?
Different measures of health effectiveness: effectiveness measures used in malaria
prevention programmes include costs per death averted (DA), cost per disability
adjusted life year (DALY), cost per sick child averted, etc. This will lead to some
difficulties in comparing studies.
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CHAPTER 4 A REVIEW OF COST-EFFECTIVENESS
ANALYSES OF MALARIA PREVENTION
4.1 Identification Of Studies For Review
Using the Academic Search Premier ofEBSCO information services, the world's
largest academic multi-disciplinary database, a comprehensive literature research was
performed to identify published cost-effectiveness analyses (CEA) of malaria
prevention in Africa context. Bibliographies of articles identified are also examined to
find additional reports. Only studies published from 1999 up to the mid of 2003 that
used African date and contained a health outcome measure are included in the current
review (CEAs of malaria prevention conducted before had been included in a
comprehensive CEA review of malaria control in Africa by Goodman et al 1999a).
Five studies are identified on the cost-effectiveness analysis of malaria prevention in
Africa context (Table 4.1). The interventions are included insecticide-treated nets
(ITN), residual house spraying (RRS), hypothetical chemoprophylaxis for infants and
environmental management (EM). CEAs of ITN included 1 from trial setting and 2
from programme settings. There was only one CEA on each intervention of RRS,
chemoprophylaxis for infants and EM. One study provided CEAs both of ITN and
RHS. The CEAs ofRHS and EM were from programme settings. Since 1999, malaria
prevention CEAs of programme settings have increased. Programme settings have
merit of being realistic reflections of compliance rate of all interventions and
retreatment rate ofITN. In the former review (Goodman et aI, 1999a) of 11 CEAs on
malaria prevention, only one was from a programme setting. In addition, one study
was identified which quoted incremental cost-effectiveness ratios (Goodman et aI,
2001). The study provides useful information of effectiveness and cost-effectiveness
comparison of ITN and RHS, but the results cannot be compared with those for other
interventions.
The studies are presented in Table 4.2 and 4.3 at the end of this chapter. This required
a number of adjustments and recalculations to put them into comparable form.
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Table 4.1 Summary of cost-effectiveness analyses of malaria prevention in sub-
Saharan Africa, 1999-2003
Reference, area Interventions Study type Outcome measure
studied and study evaluated used
year
Gonzalez, et ai, 2000 Chemoprophylaxis Hypothetical Cost per child
(based on Menendez et interventions delivered protected
a11997) based on controlled Cost per DALY*
Tanzania, 1996 trial study
Goodman et aI., 2001 Insecticide-treated nets Controlled trial Incremental case
South Africa, 1998- averted




Guyatt et aI., 2002 Insecticide-treated bets Programme evaluation Case averted
Western Kenya, 2000 Residual house Cost per person
spraying protected
Cost per infection case
prevented
Hanson et aI., 2003 Insecticide-treated nets Programme evaluation Death averted
Tanzania, Jut 1996-Jun Cost per death averted
2000 Cost per DALY
Jurg Utzinger, et aI, Environmental Programme re-analysis Cost per malaria attack
2001 management averted
Zambia, 1929-1949 Cost per death averted
Cost per DALY
Wiseman et aI., 2003
Western Kenya, Jan
1997 - Mar 1999




Cost per life year
gained
Cost per *DLYG
Cost per sick child visit
averted
* DALY = disability adjusted life year; DLYG = discounted life year gained
4.2 Insecticide-Treated Nets
Insecticide-treated net (ITNs) is a promising tool for reducing the morbidity and
mortality from malaria in endemic areas, especially when associated with effective
case-management practices (WHO 1996). Bednets are treated with a residual
insecticide, such as permethrin, which repels and kills mosquitoes and so inhibits their
feeding on humans. The efficacy of insecticide-treated nets (ITN) for the control of
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malaria in Africa, especially in children less than five years of age, has been
demonstrated by four large-scale randomised controlled trials (D'Alessandro et a1.
1995a; Binka et a1. 1996; NeviIl et a1. 1996; Habluetzel et a1. 1997). The reduction in
overall mortality in children ranged from 15% to 33% has been recorded across a
range of malaria transmission intensities. A meta-analysis (Choi et aI, 1995) measured
the incidence of infection from 10 field trials provided pooled incidence rate ratios of
infection among study groups. For the studies comparing insecticide-treated bednets
with untreated bednets, the summary incidence rate ratio for acquiring malarial
infections was 0.757, representing a reduction of24%. For the studies comparing
permethrin-treated bednets with controls without bednets, the summary incidence rate
ratio was 0.497. Insecticide-treated nets are effective in preventing malaria,
decreasing the incidence rate ratio by approximately 50% in field trials performed to
the date of the study. And another meta-analysis (Lengeler 1998) found an overall
estimate of protective efficacy of 19%.
In addition, economic evaluations of these trials have shown the use ofITNs to be
relatively cost-effective, with a cost per discounted year of life saved ranging from
US$ 9 to $77, and a cost per death averted ranging from $219 to $2959 (in 1995
prices) (Picard et a1. 1993; Binka et a1. 1997; Aikins et a1. 1998; Some 1998;
Goodman et a1. 1999).
Whilst nets normally last for several years, the efficacy of the insecticide gradually
wears off over time, so it is necessary to retreat the nets regularly. Implementation
remains very limited in sub Sahara Africa (SSA). Whilst many small-scale projects
have been established, only the Gambia runs a national programme for net treatment
(Goodman et aI, 1999a). Recent survey data showed that approximately 15% ofyoung
children slept under a net, but that only about 2% are nets that were treated with
insecticide. Untreated nets provide some protection against malaria, but their full
protective benefits can be realized only if they are regularly retreated with insecticide
(WHOIUNICEF, 2003).
There are four more CEAs of ITN found in Africa context since 1999, after the CEA
review of malaria interventions in Africa done by Goodman et al (1999a), which
included six CEAs ofITN available up to the end of 1998. Two CEAs were
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conducted alongside the trials, in the South Africa and Kenya (here called Kenya 1).
Another two evaluated malaria control programmes using social marketing in Kenya
(Kenya 2) and Tanzania. The costs of studies all included nets and insecticide.
However, two trials were using public sector delivery mechanism for nets delivery
and communal net treatment, whilst the other two were using a similar social
marketing approach. The studies in Kenya and Tanzania used a discount rate of 3%
for capital costs, compared with 5% for the South Africa study.
4.2.1 Differences in study settings and assumptions
Study settings and assumptions have important effects on the outcomes. The major
differences of the settings and assumptions among these four studies are:
a) two CEAs used programme setting, which used social marketing approach and
had big influence on both effects and cost structure, in turn had big influences
on the outcomes of studies, and the remaining two used trial condition;
b) the useful life of nets: the South Africa one used 4 years, and the remaining
used 5 years;
c) the retreatment frequency: Kenya 1 used twice a year, and the remaining used
once a year;
d) the discount rate of the base case of South African one used 5.3%, which was
the true interest rate at the time, and the remaining used 3%;
e) insecticide and dosage of insecticide: Kenya 1 used Permethrin, and others
used combinations of permethrin and pyrethroid (deltamethrin) with quite
different dosage. Synthetic pyrethroid (deltamethrin) is cheaper and longer
lasting than permethrin, and could make difference in the results.
Details of the study settings are summarised in Table 4.2.
4.2.2 Differences in results settings and outcome measures
Tanzania and Kenya I give results on two age groups of infants and children less than
5. The other two consider no specific age groups. The outcome settings, Tanzania and
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Kenya 2 give gross outcomes; Kenya gives net outcomes, which take into account of
savings to the health sector, households and funeral costs, and gives outcomes with
community effects, which are defined as the effects on cost-effectiveness of the
protection afforded to those who do not use ITNs who live in proximity «300 meters)
to households with ITNs; the South African study gives incremental gross outcome
compared with residual house spraying (RRS), and incremental net outcome which
take into accounts of savings of health sector, and households. The outcomes of the
South African study are not readily comparable with other studies. The measures were
given differently in each study. Tanzania gave DA and DALY; the key measures of
Kenya were DA and cost per sick child visit averted; and Kenya 2 used per infection
case prevented. The outcomes of these studies used US$ of different years, but this is
not considered important over the short period under study.
4.2.3 Adjusted comparable outcomes
To be able to compare these results, the gross outcomes are presented in different age
groups as prevention in infants, prevention in childhood and prevention with no
specific age group, and are summarised in Table 4.3. Several adjustments have been
made to have consensus assumptions of five years useful life of nets, retreating nets
once a year with capital cost discount rate at 3%. These adjustments are made by
recalculating gross outcomes from the initial date of Kenya 1 (Appendices 1 & 2) and
using results from sensitivity analyses. Also, the Tanzania study provided effects of
malaria prevention for infants without giving the CE ratios for the age group. The
current study makes it available and in Table 4.3, along with other comparable results.
4.2.4 Cost-effectiveness of ITNs
Two CEAs were conducted on ITNs in different study settings. Kenya 1 was from
trial in the area subject to intense, perennial malaria transmission in western Kenya
with net outcomes which included savings of health sector, households and funeral
costs, and net outcomes with community effect, which included the effect of
protection afforded to those who do not use ITNs who live in proximity «300 metres)
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to households with ITNs. The gross outcomes of Kenya 1 are calculated in Appendix
1, and the adjusted comparable gross outcomes, which adjust retreatment twice a year
to once a year, are detailed in Appendix 2. The Tanzanian study was from a
programme sponsored by KINET to explore the impact on cost-effectiveness of social
marketing delivery mechanism, where the area was also subject to intense, perennial
malaria transmission, and gave gross outcomes.
For infants, the death averted (DA) of Kenya 1 adjusted to gross cost (Appendix 1)
with retreatment annually (Appendix 2) was 1996US$ 2019, compared with Tanzania
2000US$ 2879 (The study results included 2 age-groups of infants and 1-4 year-old.
The recalculations of cost per DA and DALY for infants are in Appendix 3). The cost
per DALY of Tanzania study is recalculated as 2000US$ III (Appendix 3). Number
of deaths averted in 1-11 months infants, Tanzania reported was 52 with 65111 nets
sold, compared with Kenya 1 of 61 with 45667 nets distributed. The Tanzanian study
had lower levers of cost-effectiveness than Kenya 1. However, the adjusted gross
outcome with retreatment once a year of Kenya 1 could contribute to an over-
optimistic ratio, because the effects ofITN with reduced frequency of treatment
should reduced accordingly; yet it was not taken into account of the adjusted ratios.
From the recalculation in Appendix 1, which remains the retreatment yearly and uses
data from the original study, the cost per DA was 2000US$ 2440. Thus the cost per
DA with annual retreatment could be somewhere between 2000US$ 2019-2440.
For children less than 5, the cost per DA and DALY were given of2000US$ 1559 and
US$ 57 respectively in Tanzania study. The adjusted comparable result of Kenya 1 is
recalculated as 1996US$ 61 of cost per sick child averted (Appendix 2). Tanzania
estimated another 42 deaths averted in 1-4 age group. The results from the two studies
with regard to malaria prevention in childhood are not being able to compare directly.
There were three one-way sensitivity analyses provided by Tanzania study. It
included scenarios of effects conferred by untreated nets; level of coverage achieved
by the end of the project and duration of the effect of insecticide treatment. The best
scenario was estimated as 50% treated nets coverage with 19% untreated net, then, the
cost per DA would be 2000US$ 587 and cost per DALY US$ 22. Kenya 2 conducted
one-way sensitivity analyses on changing conditions of discount rate, frequency of net
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treatment, cost of insecticide, unwaged labour, wages of programme stuff and funeral
costs. The best scenario would be a 20% lower cost of insecticide combined with
yearly retreatment, when the cost per DA would be 1996US$ 839 (with community
effect).
The social marketing approach of ITN programme had disappointing net coverage and
retreatment rates (Cham et a11997, Chavasse et aI1999). In Tanzania study, it was
estimated that net coverage was low at 14% in Ulanga and 23% in Kilombero after
less than two years implementation. The retreatment rate calculated in Appendix 4
was disappointing at 6.3% (It's calculated Appendix 4). It could expect lower
effectiveness of the programme associated with the very low retreatment rate. The
costs of social marketing approach of ITN programme is expecting higher than public
delivery system. Tanzania used cheaper and longer lasting insecticide of pyrethroid
than Kenya 1 (permethrin). However, the biggest single item of costs contributed in
Tanzania was personnel, which offsets savings from insecticide compared with Kenya
1. With the price of nets similar, the average personnel cost of Tanzania was twice
that of Kenya 1. The lower effectiveness associated with low retreatment rate and the
high costs of implementing the programme could explain why the Tanzanian study
was much less cost effective than Kenya 1.
With similar assumptions made of 5 years useful life of net, retreatment once a year
and a 3% discount rate for capital goods (assuming similar characteristics of malaria
transmission), the two studies were highly comparable in terms of the cost-
effectiveness of different delivery mechanism.
Kenya 1 also explored the mass effects of ITN by assuming that ITN effects extended
to proximity within 300 meters of non-ITN users. The gross 1-11 months infants DA
was at 1996US$ 2039 (Appendix 1) with retreatment twice a year. There were 12
more infant's death averted with the setting. However, there was no evidence to back
the assumption. Also it is important to note that the magnitude of the community
health effects will be influenced by population density in areas neighbouring
intervention zones.
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The other two CEAs simultaneously were aimed to compare the cost-effectiveness of
ITNs with RHS. The South African study was from a trial condition, whilst Kenya 2
from a programme condition. Both studies were conducted in the area that has similar
malaria transmission characteristics: low intense, seasonal endemic transmission.
Kenya 2 assumed 2 people a net and used insecticide of deltamethrin. The study
estimated a 63% adjusted incidence rate, which was less effective than RHS (75%),
and a gross cost per case prevented at 2000 US$ 29. As for the delivery mechanism,
Kenya 2 used socio-marketing approach with expatriate personnel participation which
contributed high personnel cost - 62% of total costs. The study provided two scenarios
of sensitivity analysis - number of nets sold per community and the price of
insecticide. It was estimated that with at least 1025 nets sold per community group
(base study was 400), ITNs could compete with two cycles of RHS.
The South African study was not readily comparable with other cost-effectiveness
ratios which compared with a no intervention situation. The result setting of the study
was incremental cost-effectiveness ratios compared with RHS. The trial provided a
treated net to average 1.7 people, with sachets of the synthetic pyrethoid permethrin at
a target dose of 200mg/m2. The net retreated annually without wishing before the
retreatrnent. The study showed 69% adjusted incidence rate of ITN over RHS. In the
base case, the incremental economic cost per person of ITNs compared RHS of
2000US$1.421R8.68 (1999 price) per year; gross incremental cost per case averted of
US$ l8/Rlll; gross incremental cost per death averted ofUS$19l5/Rl17l8. In the
sensitivity analysis, it showed that including drug cost savings, it would be net
savings from using ITNs compared with RHS with a useful life of more than 8.8
years, which in the base case the useful life was 4 years, or at a net price under US$
3.57/R21.85, where in the base case the net was priced at US$12.09/R74.
If the discount rate adjusted to 3%, the incremental cost per case averted of South
African study would be at US$ 16.5 (from sensitivity analysis). If the useful life year
of nets adjusted from 4 years to 5 years, the ratio would even lower. Comparing with
Kenya 2, the cost per case averted at 2000US$29, with the knowledge from the study
that RHS cost per case averted at US$ 9, the ratio from South Africa study was much
lower than Kenya 2 (with a net useful life of 6 years and a discount rate of 5.3%, the
South Africa ratio was US$ 8.3 per case averted). In South African study, it provided
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3206 nets (5450 people with average 1.7 people a net) with 855 incremental case
averted by ITN compared with RHS, whilst Kenya study estimated 13 case averted by
providing 274 net, that is, 3.7 nets provided one incremental case averted in South
Africa study and 21 nets provided case averted in Kenya 2 study. The effectiveness of
ITN was astonishingly different of the two studies that conducted in the areas of
similar malaria transmission condition. It is hard to explain such a disparity.
The major cost of South Africa study was nets and initial insecticide, which account
for 54% of total costs; this might due to the high price of nets - the price ofUS$
12.09 per net was 2.7 times as high as the price in Kenya 2 study. In contrary, the
major cost of Kenya 2 study was organised community groups, which constituted
62% of total cost; this might due to the high salary of expatriate personnel. It signifies
ITN would be a more attractive cost-effective health investment of scarce resource
use for malaria control, if the price of ITNs in South African study could be decreased
to half, and the expatriate personnel in the Kenya 2 study could be reduced sharply.
Concerning the comparison of ITN and RHS, the results of the two studies were quite
different. In the South Africa study, ITN was more effective than RHS with an
adjusted incidence rate of 69% compared with RHS, whilst in Kenya 2 study, RHS
reduced infection risk by 75% compared with ITN 63%. It is hard to explain why the
effectiveness of ITN in South African study was much higher than that in Kenya 2
study.
CEAs of ITN covered in current study all included provision and treatment of nets.
For infants, cost per death averted ranged from 1996US$ 2019 (Kenya 1) to 2000US$
2879 (Tanzania); for children, cost per death averted was 2000US$ 1559 (Tanzania)
and cost per sick child averted was 1996US$ 61 (Kenya 1) (Appendix 2); and with no
specific age-group concerned, cost per infection case prevented was 2000US$ 29
(Kenya 2). There were 6 CEAs ofITNs covered in a CEA review of malaria
interventions (Goodman et aI, 1999a). For insecticide treatment only to existing
bednets, cost per child DA ranged from (1995) US$ 219-$829, and cost per DYLG
ranged from $9 -$27; for provision and insecticide treatment, cost per child DA
ranged from $2112-$2958, and cost per DYLG ranged from $10-$118.
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Of the four CEAs, only the South African study mentioned compliance rate of using
ITNs. People provided with ITNs may still sleep outside them due to hot weather, or
nets provided to children maybe used by adult males (Binka et aI, 1997). This may
reduce the effectiveness ofITNs and alter the CEA ratio. The compliance rate may
increase by information and education provided. Retreatment rate in South Africa
study was 100% and Tanzania 6.3% (Appendix 4). In other operational African
settings, they have often been under 25%, especially where there are some charges for
service (Chavasse et aI., 1999).
There are some new features of the CEAs covered in the current study. First, two
CEAs were from programme settings. Comparing with trials, programmes involve
routine delivery services. There is less control over the process and reflect the real
compliance rate, retreatment rate and washing frequency of using nets. Secondly,
those two programme setting CEAs also explored cost-effectiveness in different
delivery mechanism of ITN operation. The delivery mechanisms of those two were
socio-marketing approach with no free charge to nets and insecticide. To scale-up ITN
programme, the socio-marketing approach is advocated as a very important method to
compensate public health approach. However, the two studies didn't explicitly
explore the coverage rate, compliance rate and retreatment rate ofITNs. Thirdly, the
Kenya 1 study also explored mass effect of using ITNs, which the subject had
mentioned but never quantified before. In estimates cost savings, Kenya 1 included
funeral costs, which is rational and made the ratio more cost-effective. Moreover,
South African study gave incremental ratios with RHS, which could provide decision-
makers with a clearer picture of the two interventions.
Interestingly, the four CEAs ofITNs could view as two pairs of study. One pair was
from intense and perennial malaria transmission, the other from low intensity,
seasonal and epidemic-prone malaria transmission. Both pairs had two different
settings of programme and trial condition, enabling comparison of results from two
different settings directly.
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The public delivery method could be described as a government programme
established to purchase insecticide and organize net retreatment, and where necessary
distribute nets, with no charges for users who provided only limited amounts of labour
and resources such as water and detergent. The social marketing approach of the ITN
programme could be a partnership between commercial organization or non-
governmental organisation, local community, and government, normally with charges
for nets and retreatment services and gaining subsidies from government.
With regard to ITNs social marketing approach for malaria control, several issues may
need some attention. Firstly, the social marketing approach normally has
disappointing net coverage rate and retreatment rate (Cham et al.1997, Chavasse et al.
1999). The affordability of nets and insecticide has great influence on the coverage
rate and the retreatment rate of the ITNs. In turn, the effectiveness ofITN will be
great influenced. Secondly, the cost structure had been showed very different with
public health mechanism. The cost of expatriate personnel normally contributes the
biggest proportion of the total costs (Tanzania and Kenya 2), and the much higher
total costs than public delivery approach contributes to higher CEA ratios. The cost-
effectiveness of ITN social marketing approach could be great improved with lowered
price of nets and insecticide, and much reduced expatriate personnel. In the Kenya 2
study, the assumption of reducing 50% expatriate personnel could reduce 17% total
cost, which is very impressive.
Further, the sustainability of nets and insecticides supply, which need to be supported
by the sustained funds, may also be noticed. The sudden drop of a malaria prevention
programme might lead to serious malaria explosion. With acceptable cost-
effectiveness, the disappointing net coverage and retreatment rate may indicate that
the social-marketing approach of ITN programme could be used in endemic area,
which allows slow improvement in malaria control. However, concerning epidemic-
prone areas or the areas have important role as a barrier of spreading malaria to other
areas like northern KwaZulu-Natal in South Africa, where tight control is needed to
prevent explosive transmission, the social marketing approach is not ideal.
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4.3 Residual spraying
Residual house spraying involves the treating of all interior walls and ceilings with an
insecticide, and is effective against mosquitoes that favour indoor resting before or
after feeding. In the 1940s-60s, spraying the inside surfaces of houses with a residual
insecticide, principally dichloropheny1trichloroethane (DDT), was the main means by
which the incidence of malaria was reduced to zero, or near zero, in regions where
malaria was endemic (Curtis and Lines, 2000). The epidemiological concept of the
interruption of malaria transmission by residual insecticide spraying is simple. After
taking her blood-meal the female anopheles usually rests on a nearby indoor surface
such as a wall, ceiling, etc. for several hours while the blood-meal is digested and the
batch of eggs matures. Spraying of all inside surfaces of dwellings with a long-lasting
insecticide means that a substantial proportion of anopheles would be killed before
they could transmit the disease. However, mainly because of the declining ability or
willingness of governments or donors to continue funding the spraying programmes
on a sufficient scale, there has been a resurgence of malaria, though so far not to the
levels of the 1930s (Curtis and Mnzava, 2000). Now residual house spraying remains
a major component of control programmes in southern African states (WHO, 1994),
though many countries have abandoned or curtailed their spraying activities due to
concerns over the safety of DDT and environmental impact, and political and
economic pressures from international environmental agencies and donors.
It appeared that the widespread use of DDT and other residual insecticides for residual
house spraying was the most reliable, feasible and economical method for the
interrupting of transmission. It was estimated that fenitrothion residual house spraying
brought down the daily parasitological inoculation rate by 96% from the antimalaria
programmes in a large scale field trial near Kisumu, Kenya from 1972-1976 (Payne et
a11976, Fontaine et a11978). The effectiveness of residual house spraying with DDT,
pyrethoids, and malathion had been also proved by many other studies (Kouznetsov
1977, Dradley 1991, Delfini 1969, Molineaux 1980, Rowland et aI1997). However,
when recent outcomes from residual house spraying are compared with spraying
projects from the 1950s-70s, against apparently similar vector populations, the recent
results appear to be inferior (Curtis and Mnzava, 2000).
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The cost-effectiveness analysis for residual house spraying is even sparser than that of
ITNs, partly because the use of residual pyrethroids to treat bednets has become more
fashionable than house spraying.
Kenya 2 and South Africa compared CEAs of ITN and RHS for malaria control.
Kenya 2 gave gross CEAs of RHS. The study was a programme setting in an
epidemic-prone, low intense transmission area in Western Kenya, and used
lambdacyhalothrin as insecticide, which reflected the recent trends of advocating
other insecticide than DDT. The programme of RHS reduced infection risk by 75%,
while ITN was estimated as 63%, and the cost per person protected was 2000US$
0.88 and cost per per infection case prevented 2000US$ 9. The major cost
components were 76.3% insecticide, 20.4% project and 1.6% training.
The South African study didn't give CEAs ofRHS. The RHS study in South Africa
was only as a base of calculating incremental costs of ITNs. The study was from
northern Kwazulu Natal, South Africa, with similar malaria transmission properties as
Kenya 2. The RHS programme had changed insecticide from DDT to permethrin and
pyrethoids since 1996 (Goodman et aI, 2000). In the study, the ITN adjusted incidence
rate compared with RHS was 69%; the incremental cost per case averted was
2000US$ 18, and incremental cost per death averted was 2000US$ 1915. The authors
concluded that even through economic costs are higher, ITN was a cost-effective use
of resources.
The really high adjusted incidence rate of ITN over RHS of 69% indicated some other
issues. If we assume the adjusted incidence rate of using ITN compared with no
protection was 75%, then the adjusted incidence rate ofRHS would be 44%. Notice
that in South Africa, the insecticide for residual house spraying has changed as
mentioned above. Does it mean that permethrin and pyrethoid for residual house
spraying has much lower effectiveness than DDT, because after fighting with DDT
for long period of time, mosquitoes might become resistant? If it is the case, decision-
makers should pay attention to it because the study area has an important role as a
barrier area against the spread of malaria to the south.
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However, a likely explanation of this puzzle appeared from another study. Hargreaves
et al (2000) pointed out that the failure of pyrethroid spraying in preventing a rise in
malaria cases was attributed to An. funestus, which apparently had been eradicated by
DDT in the 1950s, but has re-emerged and now shows pyrethroid resistance. This
pyrethoid resistance has prompted a return to spraying with DDT.
There were two CEAs ofRHS in Goodman and Mills' review (1999a). The Garke,
Nigeria (Molineaux et aI, 1980) one was conducted from a trial. The cost per case
prevented was US$ 342. The result was much higher than the current one of Kenya 2,
and as Goodman et al pointed out, 'this result (Barlow and Grobar, 1986) is difficult
to interpret because the costs covered both research and implementation activities, and
appear to have included some costs of the accompanying drug administration and
larviciding... '. The other, Walsh and Warren (1979) used a simple model to calculate
average estimates for a rural area of SSA with twice yearly DDT spraying. The study
assumed reductions in the crude death rate of 40% and the infant mortality rate of
50% based on trials in the 1950s and 1960s, and derived a cost per adult DA was
US$584, and cost per infant DA was US$ 1402. Goodman et al (1999a) questioned
these results because the cost dates of the study were based on a WHO report (1974)
and covered adult mosquito and larval control in a 'small area of economic
importance', so it was not possible to isolate the costs of spraying alone. The study
area - an agricultural development project - was not a typical sub-Sahara rural area.
4.4 Chemoprophylaxis For Infants
Chemoprophylaxis for malaria control normally is advocated for malaria vulnerable
groups, such as non-immune travellers, pregnant women and children under 5 years of
age. Till 1998, the strategy was not implemented for children in SSA, although large-
scale programmes had been undertaken in several countries in the past, such as
Senegal, Ghana, Niger, and Burkina Faso (Goodman, 1999a).
The effectiveness of chemoprophylaxis has been reviewed by Geerligs et al (2003).
The study observed significant reductions in parasitaemia in children who received
chemoprophylaxis, which varied from 10.9% to 100%, in 42 studies. They also
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identified nine articles that reported information on child mortality. They observed
substantial evidence of mortality reduction in children who receive prophylaxis with
pyrimethamine-dapsone over 2-5 years from studies in Gambia, and no significant
effects on mortality reduction from other studies that used shorter periods of
chemoprophylaxis and included small numbers of participants.
Gonzalez et al (2000) analysed cost-effectiveness of two malaria chemoprophylaxis
control strategies for infants (under 1 year age)(chemoprophylaxis + iron, and
chemoprophylaxis) hypothetically delivered through the Expanded Programme on
Immunization (EPI) based on the study of Menendez et al (1997). The study
conducted in an area of intense perennial malaria transmission. Weekly malaria
chemoprophylaxis with a combination of 3.125 mg pyrimethamine and 25 g dapsone
per % ml (Deltaprim) were administrated at home by village health workers to infants
from 2 months to 12 months of age at a dosage of 2.5 ml per week. Daily iron
supplementation were administrated by mothers to infants from 2 months to 6 months
of age. The two control strategies were chemoprophylaxis alone or combination of the
two. The effectiveness of first episodes of clinical malaria of the two strategies were
65.9% and 5904% respectively for chemoprophylaxis + iron and chemoprophylaxis
alone. From the perspective of the health provider, the cost-effectiveness ratios were,
respectively, 1996US$ 9.7 and US$ 10.2 per disability-adjusted life year (DALY) for
malaria chemoprophylaxis with Deltaprim (a combination of 3.125 mg
pyrimethamine and 25 mg dapsone) + iron and Deltaprim alone. From a sociocultural
perspective the cost-effectiveness ratios ranged from US$ 11 to US$ 12. It also gave
cost per child protected for health care provider ofUS$ 7.3 and US$ 7.0 for Deltaprim
+ iron and Deltaprim alone respectively, compared with standard case management of
US$IOo4. The general conclusion of the study was that the strategies were highly cost-
effective and less costly than the clinical case management.
The framework of calculating CE ratios of the study was different with those of other
malaria studies in Africa. The results in the view of health provider included
intervention costs and costs of clinical case management to the intervention-
implemented groups who were not protected from the interventions. The results of the
study were not readily comparable with the other malaria chemoprophylaxis control
settings and malaria prevention settings in Africa. To provide comparable gross ratios,
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the current study uses the initial data of interventions costs and effects estimates, and
recalculates the ratios. Details are in Appendix 5. The gross cost per DALY of
chemoprophylaxis plus iron was 1996US$ 5.0, gross cost per DALY of
chemoprophylaxis was 1996US$ 4.1. From costs data of the study (Gonzalez et aI,
2000, plO 1), the costs of clinical malaria treatment was similar with the intervention
costs of chemoprophylaxis plus iron, and much higher than the intervention costs of
chemoprophylaxis. It indicated that net cost-effectiveness ratios, which include
malaria treatment savings and savings from households, would be negative, in other
words, the intervention was a net saving for both health providers and households,
which was consistent with the conclusion of the study.
In other studies, malaria chemoprophylaxis alone was estimated to cost US$ 143
(1990 prices) per death averted in Gambia (Picard et aI, 1992), and cost US$2.8 per
child protected per season, compared with the current one ofUS$ 2.7 at 1996 prices.
Generally, chemoprophylaxis appeared to be more cost-effective than standard case
management! or net treatment in the both chemoprophylaxis studies conducted in
Tanzania and Gambia. However, compliance might need more investment as
mentioned in Picard et al (1992) study, average compliance was 60% and dropped to
33.6% in the longer period.
4.5 Environmental management for malaria control
Environmental management for malaria vector control was first used in Selangor,
Malaysia, where vegetation clearance and drainage and filling of aquatic habitats in
forested wet-lands and in towns were used to control one of the local lowland malaria
vectors (Sandosham, 1959). Currently, there is a renewed interest in environmental
management (EM) among vector control specialists, partly in response to a series of
problems faced by many vector control programme; increased costs of insecticide
production, marketing, and distribution; stricter toxicologic testing; vector resistance
to certain insecticides; and limited field success with biological control measures
(Lacey and Lacey, 1990). Solutions are being sought not solely through traditional
eradication programmes, but through the use of EM, a deep understanding of vector
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ecology, and the integration of the various control strategies (chemical, biological,
genetic, EM, etc.) (Ault, 1994).
Scientific knowledge of the often adverse ecological and public health effects of large
dams, other development projects and vector control strategies has grown, beginning
in the 1950s, but most noticeably since the 1970s (Farvar et al. 1972, Stanley et al.
1975, Scott et al1982, Service et al. 1989). In parallel, there arose a wider application
of ecologic principles in insect pest and vector management. EM can provide cost-
effective means to suppress, diverse and exclude vectors associated with rural
development and urbanisation, and public health improvement in the tropics. It often
promotes the use of health and sanitation education of appropriate technologies,
clean-up campaign, and community participation with an emphasis on self-help
strategies for vector control (Ault, 1994).
One cost-effectiveness analysis of environmental management for malaria control is
found from re-analysing programmes conducted between 1929-1949 by Utzinger et al
(1999). They undertook a cost-effectiveness analysis of EM for malaria control from a
large-scale, multifaceted malaria control programme that incorporated environmental
management as the central feature. The programme was launched in 1929 and
implemented for 2 decades at copper mining communities in Zambia before
dichlorodiphenyltrichloroethane (DDT) was widely used. The full package of control
measures, which was targeted mainly at source reduction of larval habitats of the
predominant malaria vector, consisted of vegetation clearance, modification of river
boundaries, draining swamps, oil application to open water bodies and house
screening. Part of the population also benefited from quinine administration and was
sleeping under mosquito nets. Within 3-5 years, malaria-related mortality, morbidity
and incidence rates were reduced by 70-95%. Over the entire 20 years of
implementation, the programme had averted an estimated 4173 deaths and 161205
malaria attacks. The estimated costs per death and malaria attack averted were US$
858 and US$ 22.20 respectively. Over the initial 3-5 years start-up period, the costs
per disability adjusted life year (DALY) averted were US$ 524-591, and in the longer
term, as the maintenance costs were much lower, US$22-92 per DALY averted.
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The programme was highly successful. With fewer adverse ecological effects, sharp
declines in malaria-related outcome measures were observed shortly after the
programme was initiated, and after 3-5 years the package exhibited a high level of
performance. With effectiveness of quinine administration, sleeping under mosquito
net and last 5 years DDT spraying, the cost-effectiveness ratios, which the costs only
included recruitment of 300 men for vegetation clearance, modification of river
boundaries and drainage of swamps, and the annual maintenance of these
interventions, seem to be underestimated. Moreover, the study excluded costs of
supervision of mine management and entomological surveys which formed the
knowledge base for tailoring environmental management strategies. The ratios are
therefore bottom lines of cost-effectiveness of EM intervention. Comparison of these
ratios with other CEAs is difficult.
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Table 4.2 Base-case settings and assumptions
Studies ITN-Tanzania ITN- Kenya 1 ITN- Kenya 2 ITN- South Africa RHS Chemoprophylaxis Environmental
(based on Menendez management (EM)
C et a11997)
Author/year Hanson et al., Wiseman et aI., Guyatt et aI., 2002 Goodman et al., Guyatt et al., 2002 Gonzalez et ai, 2000 Utzinger et ai, 2001
2003 2003 2001
Place/year Southern Westem Kenya, Westem Kenya, Northern Kwazulu Western Kenya, Kilombero District, Copper mines in
Tanzania, Jul Jan 1997 - Mar 2000 Natal, South Africa, 2000 Tanzania, 1996 Zambia, 1929-1949
1996-Jun 2000 1999 1998-1999
Price in US$ 2000 US$ (Tsh 1996 US$ 2000 US$ 2000 US$ 2000 1996 1995
year 803/US$) (R6.12/US$)
Setting Programme Group-randomised Programme Trial Programme Randomised Large-scale, multi-
controlled trial controlled trial faceted programme,
with centre feature
of EM
Malaria Intense and Intense and Epidemic-prone, Seasonal endemic Epidemic-prone Intense perennial Hyperendemic
transmission perennial perennial low intensity, stable but low intensity area, low intensity, malaria transmission malaria
stable transmission transmission
Delivery Social marketing Research program Social marketing Using existing 4 mobile teams Expanded Organised by
mechanism with expatriate and community with expatriate health control (Merlin and health programme on mining
personnel; users partnership; free in personnel; users teams, free in staff), free to Immunization (EP1) management, with a
share costs charge of nets and share costs charge of nets and charge team of300 men
insecticide insecticide
Target Children less than Children less than Infants
group 5 and infants 5 and Infants
Design -I: Deltamethrin, -I: Permethrin -I: K-othrine 1% SC -I: Deltamathrin -I: [con 10% WP 1) Daily iron supp. -Detailed
lambdacyhalothrin - ID: 0.5g of (deltamethrin) (98) /permethrin (Iambda- administrated by entomologic
-ID: 20mg/m2 permethrin /m2 of - P: 285 sold at US$ (99) cyhalothrin, 100 mothers surveys for tailoring
-P: Nets: US$4.7 netting 0.64, the rest at US$ - ID: 200mg/m2 g/kg ai) 2) Weekly the strategy
(sold 65111) - P: Duty free price 4.47 - P: Nets R74/ US$ -Round: l/year chemoprophylaxis -Targeting the larval
Insecticide kit: of insecticide - NUL: 5 years 12.09 administrated at stage: vegetation
US$ 0.42 (sold Nets: US$ 5* - NC: Assuming 2 Deltamethrin: R home by village clearance,
51
24393) (45667 nets) people a ITN 5.911 US$ 0.96 health workers modification of
-NUL: 5 years - NUL: 5 years - RP: lIyear Permethrin: -Design 1: 1) + 2) river boundaries,
• NC: 14% - NC: 1.34 people RI0.961 US$ 1.79 -Design 2: 2) draining swamps,
Ulanga,23% per ITN - NUL: 4 years oil application to
kilombero - RP: 2/year - NC: 1.7 people open water bodies
- RP: l/year per ITN and house screening
- **RR: 6.3% - RP: lIyear -With part of
- RR: 100% quinine
administration and
sleeping under nets
Discount 3% 3% 3% 5.3% 3% 3% 3%
rate
Life 54.2 years at birth, Average 48.5 years Data not available At births of 50 years
expectancy 58.6 years at the at six months of
age of 3 years age
Major ***Personnel: ITNs: 40% Organised Nets & initial Insecticide: 76.3%
economic 27.7%, nets and Staff: 21% community groups: insecticide: 54% Project: 20.4%
cost packaging: 25.4%, Insecticide: 9% 62% *DoH personnel: Training: 1.6%
component insecticide: 5.5 % Nets: 19% 21%
(30% financial Insecticide: 19% Insecticide and
cost borne by (cost per net retreatment: 15%
users) recovered by users
was US$ 3.20)
Compliance 98%
*1: insecticide, ID: insecticide dosage, P: price, NUL: net useful life, NC: net coverage, RF: retreatment frequency, RR: retreatment rate, DoH:
department of health.
** Retreatment rate calculation is in Appendix 4
***It's calculated from Tanzania study's table 3 - annual economic cost (2000 prices) ofKINET
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Table 4.3 Gross cost-effectiveness results for interventions using comparable outcome measures
Reference Area studies and Intervention Effectiveness Outcomes Sensitivity analysis available
study year evaluated
Prevention in infants
Hanson et aI. 2003 Southern ITNs (social 27% protective efficacy Death averted: 52 -Effects conferred by untreated nets
(ITN-Tanzania) Tanzania, JuI. marketing approach) ***Cost per DA: 2879 -Level of coverage achieved by the end
1996-Jun. 2000 ***Cost per DALY: III of the project
(US$ in 2000 price) -Duration of the effect of insecticide
treatment
Wiseman et aI. 2003 Western Kenya, ITNs (trial) 23% protective efficacy Death averted: 61 -Discount rate: 6%, 10%
(ITN-Kenya 1) Jan. 1997- Mar. 27% reduction in the **Cost per DA: 2019 -Frequency of net impregnation: once a
1999 number of sick child (US$ in 1996) year
-Cost of insecticide: 20%
increase/decrease
-Unwaged labor: 25% above/below
-Wages of programme staff: 50%
reduction
-Funeral costs: 50% reduction
Gonzalez et aI. 2000 Tanzania, 1996 Chemoprophylaxis Effectiveness of ****C+I, cost per DALY: 5.0 -Low effectiveness estimate at C+I
(date based on hypothetically *FECM: *C+I: 65.9% ****C, cost per DALY: 4.1 39.7% and C 32.9%: health provider
Menendez et aI. 1997) delivered through *C: 59.4% perspective, DALY ofC+I: US$ 21.9,
(Chemoprophylaxis) EPI DALY of C: US$ 25.8; sociocultural
perspective, DALY of C+I: US$ 26.2,
DALY of C: US$ 31.5
-Varying percentages of episodes
treated through the health care system
-Two-way sensitivity analysis,
comparing the cost-effectiveness of C+I
with standard case management
Prevention in
childhood
Hanson et aI. 2003 Southern ITNs (social 27% protective efficacy Death averted: 97 -Effects conferred by untreated nets
(ITN-Tanzania) Tanzania, JuI. marketing approach) Cost per DA: 1559 -Level of coverage achieved by the end
1996-Jun. 2000 DALY: 57 ofthe project
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-Duration of the effect of insecticide
treatment
Wiseman et al. 2003 Western Kenya, ITNs (trial) 23% protective efficacy **Cost per sick child averted: 61 -Discount rate: 6%, 10%
(ITN-Kenya 1) Jan. 1997- Mar. 27% reduction in the (US$ in 1996) -Frequency of net impregnation: once a
1999 number of sick child year
-Cost of insecticide: 20%
increase/decrease
-Unwaged labor: 25% above/below
-Wages of programme staff: 50%
reduction
-Funeral costs: 50% reduction
Prevention with no
specific age-group
Guyatt et aI, 2002 Western Kenya, ITN (social ITN: 63% adjusted ITN: Case averted: 13 cases/ 274 -Number of nets sold per community
(ITN-Kenya 2 and 2000 marketing approach) incidence rate nets group
RHS) RHS RHS: 75% Cost per infection case averted: 29 -Price of insecticide
RHS: cost per infection averted: 9
(US$ in 2000 price)
Jurg Utzinger et aI, Zambia, 1929- Environmental In 3-5 years: incidence Averted 4173 deaths and 161205
2001 1949 management rate reduced 70-95% malaria attack
(EM) DA: 858
Cost per malaria attack averted:
22
DALY: 22-92
(US$ in 1995 price)
*FECM: first episodes of clinical malaria; C+I: chemoprophylaxis +iron; C: chemoprophylaxix; CCP: cost per child protected.
** Recalculated from original data, details are in Appendix 2
*** Recalculated from original date, details are in Appendix 3
**** Recalculated from original date, details are in Appendix 5
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CHAPTER 5 CEA STUDIES OF MALARIA
PREVENTION AND MALARIA CONTROL
5.1 CEA of Malaria Prevention
5.1.1 Results and their comparability
Cost-effectiveness analyses of malaria prevention covered in this study include
interventions ofITNs, RHS, chemoprophylaxis for infants, and environmental
management. The most effective way of malaria prevention was environmental
management with an adjusted incidence rate of 78% (70-95%). For infants, ITNs
provided cost per death averted ranged from US$ 2019 (Kenya 1) - US$2879
(Tanzania) and cost per DALY US$ 111 (Tanzania); chemoprophylaxis provided cost
per DALY US$ 4.1 (Gonzalez et aI, 2000) and cost per DALY of chemoprophylaxis
plus iron US$ 5.0. For children, ITNs gave a cost per DA US$ 1559 (Tanzania), cost
per DALY US$ 57 (Tanzania) and cost per sick child averted US$ 61 (Kenya 1). For
non-specific age-group, EM gave cost per DA US$ 858 and DALY US$ 57; ITNs
gave cost per infection averted US$ 29, and RHS US$ 9. According to the guideline
that any intervention with a cost per DALY below US$ 150 is an attractive use of
resources, in a low-income country (WHO, 1996), ITN, chemoprophylaxis and EM
can be considered as cost-effective means of preventing malaria. Meanwhile, with the
knowledge of lower ratios of RHS than ITN (Kenya 2), RHS could also be included.
To meaningful compare CEA results, the studies must have included a comparable
range of costs and effects and followed a similar methodology, for example to value
community time, and discount costs and effects. In addition, it's better to have
measures of effectiveness that is common across the interventions being compared
(Goodman et aI, 1999a). In the study, the results settings and effectiveness measures
of these studies are impossible to adjust and remain the same. When these results are
compared, there is a need to identify the age groups that results were taken from, and
bear in mind the different effectiveness measures. However, the author has adjusted
the settings and assumptions of these studies more comparable. The South African
study remained non-comparable with the others because it gave incremental ratios
with RHS.
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Also, it is important to notice that studies from trials, which may be unrepresentative
of routine service delivery, may have over-optimistic estimate of effectiveness and
cost-effectiveness. Therefore costs are adjusted to remove any research-related
expenses and compliance is likely to be much higher than operational settings. The
study of environmental management excluded costs of entomological surveys,
management supervision, nets provision, quinine treatment and DDT intervention
during the last 5 years of the programme, so the cost-effectiveness ratio may appear
more attractive than reality. Further, the adjusted ratios, such as retreatment frequency
of ITN from biannually to annually, which may affect the effectiveness accordingly,
may lead to over-optimistic outcomes.
In addition, cost-effectiveness ratios are influenced by various factors specific to each
intervention. These factors cannot be altered easily especially the geographic settings,
like epidemiological conditions and demographic factors, so that, one-way or even
multi-ways adjustments of settings may still provide distorted ratios. These include,
according to (Goodman et aI, 1999a; Goodman et aI, 1999b):
.:. The length of the transmission season, which may influence the retreatment
frequency of ITN and the rounds per year needed of RHS;
.:. The intensity of malaria transmission, which through effects could influence the
ratios;
.:. The population density, which may influence the mass effect of ITN, and the
effectiveness of RHS;
.:. The scale of intervention, which may influence the costs especially using social-
marketing approach for ITN;
.:. The price of inputs, such as nets, insecticides and salaries;
.:. The delivery system - public system or social marketing approach - which could
influence both costs and effects;
.:. Behavioural factors, such as compliance with chemoprophylaxis regimens and
usage and retreatment rates for nets;
.:. The degree of existing infrastructure, and
.:. The degree of drug and insecticides resistance.
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Moreover, immunity levels, the acceptability of the intervention to local people and
the availability of managerial capacity, all contribute differences in cost-effectiveness
ratios. Along with the progress of the techniques of cost-effectiveness analysis,
researchers tend to customise their study designs specific towards their interests and
local conditions, like the chemoprophylaxis study in Tanzania, the South African
study, and Kenya 1. The fact made inter-study comparison of cost-effectiveness
concerning malaria prevention more difficult.
5.1.2 CEAs of malaria prevention in sub-Sahara Africa before 1998
Goodman and Mills (l999a) reviewed 11 CEAs of malaria prevention available up to
the end of 1998 that used African data. The review covered malaria prevention
interventions of insecticide-treated nets, residual spraying, chemoprophylaxis and
hypothetical vaccine for children, chemoprophylaxis or intermittent treatment for
pregnant women. For ITNs, cost per DA ranged from 1995 VS$ 219-2958, cost per
DYLG ranged from $9-118; for hypothetical vaccine, cost per DA was $296, cost per
DYLG ranged from $0.36-$621; chemoprophylaxis for children, cost per DA was
$167; and chemoprophylaxis for pregnant women, cost per child DA ranged from $81
- 950. In addition, Goodman, Coleman and Mills (l999b) used a modelling approach
based on probability sensitivity analysis and obtained data from published and
unpublished sources and consultations with researchers and programme managers to
calculate ranges for the cost per disability adjusted life year (DALY) averted. They
found that in a very-Iow-income country, for insecticide treatment of existing nets, the
cost-effectiveness range was V.S. $4-10 per DALY averted; for provision of nets and
insecticide treatment, $19-85; for residual spraying (two rounds a year), $32-58; for
chemoprophylaxis for children, $3-12 (assuming an existing delivery system in
place); for intermittent treatment of pregnant women $4-29; and for improvement in
case management, $1-8.
The ranges ofCE ratios from the current review, the review from Goodman et al
(l999a) and the modelling study from Goodman et al (1999b) for ITN, RHS,
chemoprophylaxis and EM are summarised in Table 5.1. The whole ranges ofCE
ratios for ITN, RHS, chemoprophylaxis and EM that combined the three studies are
displayed in Table 5.2, regardless of age group. While a strict comparison of CEAs of
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malaria prevention from various settings is impossible, the table presents a general
sense of cheapest among these cost-effective malaria prevention methods. In general,
chemoprophylaxis appears to the cheapest solution for malaria prevention, followed
by RHS 1 round a year, RHS 2 rounds a year, ITN with existing nets and ITN with net
provision and treatment. The EM ratios provided by Utizinger et al (2001) were little
higher than ITN with net treatment only. However, it was impossible for the study to
isolate costs and effects from other interventions, such as, nets, cloroquine
administration and lost five years ofDDT spraying. The ratios of EM could be
expected to be much higher and may come in between ITN with existing nets and ITN
with net provision and treatment.
Earlier malaria economic evaluations in world context can be found from Barlow and
Grobar (1986) and Mills (1987). Several cost-effectiveness analyses of malaria
control and eight cost-benefit analyses of malaria control were covered Barlow and
Grobar (1986), which used worldwide data. Mills (1987) conducted cost-effectiveness
analysis of malaria control in Nepal.
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Table 5.1 The ranges of cost-effectiveness ratios of malaria prevention covered
by the current review, and earlier studies ($US)
Current review Review of Goodman et ai, Modelling
1999a study of
(USS in 1995 price) Goodman et
al,1999b
Cost per Cost per Cost per DA Cost per Cost per
DA DALY DLYG DALY
Prevention in
infants
ITN with net treatment
only







ITN with net treatment 219-829 9-27
only






ITN with net treatment 4-10
only
ITN with net provision 19-85
and treatment
RHS I round annually 16-29





Table 5.2 The general range of cost-effectiveness ratios of main malaria
prevention interventions ($US)
Interventions
ITN with net treatment
ITN with net provision and treatment
RHS I round annually
RHS 2 rounds annually
Chemophophylaxis with existing delivery system
Environmental management












5.1.3 Cost-effectiveness data and public health policy
National and international police-makers urgently need to know which strategies are
best for malaria prevention. Economic evaluation methods, and in particular cost-
effectiveness analysis, can provide important information for identifying the
interventions that present the best value for money. However, CEA of malaria control
is sparse. No CEAs were found of untreated nets, other methods of personal
protection (such as coils) and the control of epidemics. There is only one cost-
effectiveness re-analysis found of environmental management for malaria control
from a programme implemented during 1929-1949. For Africa, there are two CEAs of
chemoprophylaxis for children, two for infants; two of hypothetical vaccine for
children, and three of RHS.
More studies have been conducted since the review of Goodman et al (1999a). There
are several studies filled the gap of CEA knowledge base of malaria prevention, such
as a study of environmental management, ITNs studies with social-marketing
approach and RHS with other insecticides than DDT. However, the studies from
socio-marketing settings ofITN programmes didn't explore the net coverage rate, the
compliance rate and retreatment rate. Moreover, while there are several successful
instance of environmental management of malaria control, the CEA of EM are few.
The current available CEA on EM is only one and with limited data of costs and
effects, the study excluded costs of entomological surveys, management supervision,
nets provision, quinine treatment and DDT intervention during the last 5 years of
programme, and effects included all methods used, therefore, the cost-effectiveness
60
ratio may appear more attractive than reality. There is a critical need ,for more CEAs
with quality costs and effects data.
Further, concerning the South African study, the effectiveness of ITN with
deltamathrin and permethrin was much higher than RHS with lambdacyhalothring -
the adjusted rate was 69% compared with RHS, which had opposite results with in
similar malaria transmission area of Kenya (the study had 75% adjusted incidence rate
ofRHS with lambda-cyhalorin and 63% adjusted incidence rate oflTN with
deltamathrin) (Guyatt et aI, 2002). The low effectiveness of the insecticide urges us to
compare the effectiveness of RHS with DDT and other insecticides, especially where
DDT was used before. As the South African study area plays a very important role of
preventing malaria spread further down to southern, if the effectiveness of RHS with
other insecticides drop sharply compare with the previous use of DDT, and RHS is
still using as a major intervention of malaria prevention, then the potential danger of
malaria spread to other areas will be high. Although WHO now recommends DDT
spraying only in certain circumstances (e.g. for control of epidemics, areas of
economic importance, refugee camps and initial protection of non-immune settlers in
development areas), this should not prevent further scientific studies of DDT
effectiveness analyses and cost-effectiveness analyses, especially where malaria
prevention of RHS tend to switch or have switched from DDT to other insecticides.
The words from Goodman et al (1999a) are worth attention as regards methodology:
... only studies of ITNs provide a good basis for assessing allocative efficiency.
Data to construct similarly comprehensive and methodologically sound
estimates with ITN studies for other interventions are currently lacking and
urgently required ... More studies are evidently needed, but this takes time and it
will never be possible to do studies on every possible situation... Also, in view
of rapid growth in drug resistance ... , the likely development of pyrethroid
insecticide resistance ... , and the possible reduction in the rate of immunity
acquisition with effective protection ... , it is essential to consider potential
changes in cost-effectiveness over time.
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5.2 Malaria Prevention Interventions
5.2.1 Malaria chemoprophylaxis
From Table 5.2, which summarized results from the current CEA review, the review
by Goodman et al. (1999a) and the modelling study by Goodman et al. (1999b), it is
clear that malaria vaccine and chemoprophylaxis interventions in the sub-Sahara are
among the most cost-effective of malaria prevention measures. However, malaria
vaccine is still at the stage of laboratory development or small-scale experiment. And,
wide-use of malaria chemoprophylaxis is not recommended, since it could
substantially increase the growth of drug resistance, which would lower the cost-
effectiveness of this intervention and possible threaten the provision of effective case
management. Chemoprophylaxis is promoted to be used by target groups, such as
pregnant women and travellers. So, for large-scale malaria prevention, the choices are
mainly left among ITNs, RHS and environmental management.
5.2.2 Insecticide treated nets
The cost-effectiveness ofITNs programmes is sensitive to several factors. The first is
the compliance rate of proper using ITNs. It is important to make sure that nets are
used and especially used by malaria-vulnerable groups, even during seasons when
their use is uncomfortably hot and there may not be enough biting by nuisance insects
to make net use seem worthwhile. It is also important to make sure that people,
especially children, go to bed before vectors start biting and do not get up before they
stop. Nets must be kept in good repair, hung carefully, brought out for retreatment
when required and not washed before retreatment. Second, considerable managerial
skills are necessary for implementing ITN programmes. With limited implementation
of ITN programmes in sub-Sahara Africa (Goodman et aI, 1999a), the managerial
skills required for effective operation are immense for most poor malarious countries,
especially when the socio-marketing delivery approach is used. The scaling-up of the
intervention might need quite a number of expatriate personnel, which could increase
the costs sharply (Tanzania and Kenya 2). Third, ITN generally is the most expensive
intervention among those cost-effective malaria control measures (Table 5.2). With
62
limited implementation ofITN programmes in sub-Sahara Africa (Goodman et aI,
1999a), ITN programmes mainly need to provide and retreat nets, which is the most
costly intervention among other cost-effective methods. Besides, every 4-5 years, nets
need to be renewed. With the limited incomes of those poor malarious countries, the
cost-effectiveness of the intervention will be reduced by low ITN coverage rate and
retreatment rate, if charges are required. If financed by donors, the sustainability of
funds should be assured - the sudden stop of malaria prevention could lead malaria
infection explored and wide spread.
Finally, ITNs may delay children's immunity, which could lead to the intervention no
longer cost-effective. In 1999, Coleman et aI, Guyatt et al and Kariuki et al pointed
out that ITNs effective but may delay children's immunity. Research found that
children sleeping under ITNs had markedly lower levels of anti-malaria antibodies
than children not sleeping under bednets. Guyatt et al (1999) demonstrate that delayed
immune acquisition is not a problem per se, but that the critical issue is whether it
occurs immediately following the implementation of an ITN programme or whether it
builds up slowly over time. In the 'worst scenario', where ITN immediately increase
malaria mortality due to reduced immunity, the intervention might actually cost lives.
In other words, it might be better to not use ITNs. On the other hand, if reduced
immunity takes two years to develop, ITNs would still fall into the category of
excellent value for money compared to other health interventions, saving a year oflife
at a cost of between US$ 25-30. Coleman et al (1999) used model to present the cost
and disability adjusted life year (DALYs) per child aged 1-119 months for a sub-
Sahara population with and without ITNs. With mortality and morbidity reductions
due to ITNs in children aged 1-59 months and rebound in the 5-9 years class, the cost
per DALY averted is below US$ 150 up to a rebound rate of 39%, up to an 84%
rebound rate it is highly likely that the intervention will be DALY-averting, that is the
DALYs averted by the intervention overweigh DALYs incurred through rebound rate.
With reductions confined to children aged 1-35 months and rebound in the 3-6 years
age class, the cost per DALY is highly likely to fall below $150 only up to 2.5%, and
with a rate in excess of 11 % one can no longer be certain that the intervention is
DALY-averting. Long-term surveillance included as part of ITN interventions is
crucial with particular attention the age range over which rebound may occur.
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With regard to the social-marketing approach of ITN programmes, it is clear that the
method used in epidemic-prone areas and areas which play an important role in
preventing spread to other areas, is not ideal. The net coverage rate and net
retreatment rate could be low suffered by low affordability of households in many
malarious countries in Africa. Therefore, the ability of preventing malaria explosion
of the method is in question. Curtis and Mnzava (2000) expressed their opinions on
social-marketing approach of ITN concerning of social aspect, noting that it would be
deplorable if a switch from house spraying to insecticide treated nets was, in effect, a
means of removing the responsibility for payment for malaria control from affluent
taxpayer to the narrow shoulders of subsistence farmers, whose poverty arises partly
from their affliction with malaria.
In fact, ITNs for malaria prevention could be viewed as a personal protective device
rather than a vector control strategy. The intervention aims to create a relative
malaria-safe personal environment via repellent of malaria vector rather than actively
deal with the source of the transmission by killing vector larval and adult larval. The
macro-environment - outside of the ITN - is still malaria dangerous. The strategy,
whether using public delivery system or social-marketing approach, is appropriate for
malaria prevention in endemic areas, where allow improvement of malaria situation at
any pace without intense control of compliance rate, net coverage and retreatment
rate, financial constrained governments shifting a bit of their responsibility to
affordable households.
5.2.3 Residual House Spraying
The comparison of efficacies of using RHS and ITNs against malaria vectors by
Curtis and Mnzava (2000) reviewed data from spraying projects conducted in the
1950s-70s, some of recent insecticide-treated net projects in comparable ecological
situation and six recent side-by-side comparisons of projects using ITN or RHS. They
concluded that by all the entomological and malariological criteria recorded,
pyrethroid-treated nets were at least as efficacious as house spraying with DDT,
malathion or a pyrethroid.
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For effective implementing RHS, it is necessary that the sprayed walls not be painted
before the end of the transmission season. Curtis and Mnzava (2000) pointed out that
spraying operations suffered from low staff morale and lack of public understanding
and support. This could be corrected by comprehensive education programmes
(Goodman et aI, 2001). The compliance requirement is less intensive than ITNs. Also,
RHS generally is less expensive than ITNs (Table 5.2), the most important feature of
malaria prevention for most malarious countries. The biggest cost component of the
strategy is insecticide costs would be less with no expatriate personnel participants.
Further, RHS could offer a malaria safe macro-environment for epidemic-prone areas
and economic-important areas. It is clear that RHS is the most important malaria
prevention strategy for such areas. As Curtis and Mnzava noted, in epidemic-prone
areas one can envisage a "fire-brigade" approach with a trained spray team equipped
with spray pumps and insecticide, ready to go as soon as prediction indicators warn of
an imminent epidemic. And it seems more feasible to maintain a capacity to react by
spraying, than to maintain large stocks of nets for issue in the event of an epidemic.
It could expect that RHS is a more favourable approach for malaria prevention - it's
simpler, faster and cheaper in concerning to all challenges of operation, management
and finance - regardless to the authority (Roll Back Malaria) promotion ofITNs.
However, the strategy is facing the fears of damaging environment, especially
concerning the use ofDDT.
5.2.4DDT
The widespread use ofDDT in the 1950s and 1960s all but eliminated malaria in
several developing countries and saved an estimated 500 million lives by 1970
(Economist, 2000). Since then, its use has shrunk. Of the roughly 100 countries where
malaria is endemic, only 23 now employ DDT to fight malaria (WHO, 1999). And
that is frequently the fault of aid donors who help to finance the battle of against
malaria (Economist, 2000). The Environmental Protection Agency banned DDT in
1972. Since then, American and international environmental and aid agencies
pressured African, Asian and Latin American nations to abandon DDT, fearing its
widespread use would endanger wildlife.
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While there is some evidence that DDT causes environmental harm, damage occurred
only during widespread agricultural use ofDDT in the 1950s and 1960s, no study in
the scientific literature has adequately shown any human health problem resulting
from DDT (Bate and Okonski, 2001; Economist, 2000). Also, it is not likely that the
tiny quantities used in house-spraying have any serious effect on the environment.
Amir Attaran, another Harvard academic, estimates that the volume of DDT used to
protect the entire high-risk population of Guyana for a year is equivalent to what a
farmer might spray on to a single field of cotton, noted Dinan and Bieron (200 I). By
contrast, when DDT-spraying stops, the number of malaria cases frequently explodes
(Dinan and Bieron, 2001; Roberts and Laughlin, 1997).
It is clear that DDT is the cheapest and most effective method for killing mosquitoes
and many countries rely on its use for the control of malaria (Donan et aI, 2001;
Economics, 2000; Roger Bate and Kendra Okonski, 2001; Roberts and Laughlin,
1997). In 1990, cost comparisons ofDDT and alternative insecticides for malaria
control by the World Health Organization found DDT to be considerably less
expensive than other insecticide, which cost 2- 23 times more on the basis of cost per
house per 6 months of control. Recent research (Walker 2000) compared current price
quotes from manufactory and WHO suppliers for DDT and appropriate formulations
of nine other insecticides, showed that DDT is still the least expensive insecticide on a
cost per house base. The recommended alternatives, pyrethroids, are four times as
expensive as DDT and also less effective (Economists, 2000). It is critical for most
malaria endemic countries, especially for very poor countries, like Zambia or
Mozambique, where the annual health budget is less than $5 a person (Dinan and
Bieron, 2001). The government ofIndia, within its National Anti-Malaria Program
(NAMP), uses a number of insecticides, including DDT, malathion, deltamethrin, and
others. NAMP concluded that it cannot use these more expensive insecticides with
leaving tens of millions of Indians unprotected from malaria (Bate and Okonski,
2001).
Second, there is no need to drop DDT from crop dusters on acres of farms; low-dose
use of DDT indoors is unlikely to cause any significant harm to the environment or
people (Bate and Okonski, 2001). Third, DDT use for the last 6 decades in southern
66
Africa has not led to the development of resistance
(http://www.malaria.org.zw/pubs/vectorl.pdf). In contrast, mosquito resistance to
synthetic pyrethroids has been reported in Ndumo, South Africa (Hargreaves et al.
2000).
DDT now is permitted in limited use. However, it is still far from ideal. That is
because countries that use DDT for malaria control must record and report how much
they use, how they use it and where they get it from (Economist, 2000; Bate and
Okonski, 2001). This may not sound onerous, but in places such as Mozambique,
where the annual budget for fighting malaria is less than 30 cents a person, any
additional bureaucracy could prove to be a big drain on resources. As Economist
notes, concern for the environment is generally an admirable thing, but obsession, at
the cost of human lives, is of more questionable value.
5.2.5 Environmental management
The environmental management of malaria prevention has fewer environmental
adverse effects. It often promotes the use of health and sanitation education of
appropriate technologies, clean-up campaign, and community participation with an
emphasis on self-help strategies for vector control (Ault, 1994). The cost and cost-
effectiveness of EM from the study ofUtzinger et al (2001) was impressive but did
not reflect the true picture of it, as mentioned in sections 4.5 and 4.6.1. However,
environmental management is often a cost-effective strategy for vector control for
several reasons. As Ault (1994) noted, it relies on ecological principles and
knowledge of the vector's natural history. The targeted approach makes the strategy
less costly. Also, it can be integrated relatively easily with other control measures, and
can be an appropriate technology chosen for the level of socio-economic development
and resources available in a community. Further, its tactics lend themselves to
community participation, which could substantially reduce the implementation costs
compared with other interventions that need expatriate personnel. Moreover, when
EM costs are embedded in the planning stages of developmental projects (e.g., dam
and irrigation projects) or spread among multiple sectors of national economy (e.g., in
both the health and agricultural sectors), the costs of EM can be reduced, making EM
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a more cost-effective strategy than say a chemical-only control strategy that cannot
spread costs and share resources outside the Ministry of Health. Intemational bank
such as World Bank often prefer to fund multisectoral projects and programmes.
Thus, EM projects that engage professional and technical staff, labour, and other
resources from multiple sectors can be cost-effective, particularly when capital (loans,
grants) invested by development banks substitute for local (national) capital (Ault,
1994).
Environmental management could be easily integrated with other malaria control
measures. It should be beneficial and preferable that integrate environmental
management with spraying. The entomological survey that is necessary for EM could
also benefit for effective and wise use of residual spraying. The targeted approach
could have less wastage of spraying with fewer environmental effects, such as killing
much fewer beneficial insects and causing much fewer injuries in other nontarget
animal populations, meanwhile could also enhance the effectiveness of malaria
prevention - environmental management of malaria prevention mainly is targeted at
killing malaria vector larval, and spraying at killing malaria vector adults, therefore,
the integrated approach could great reduce the malaria vector population and enhance
the effectiveness of malaria prevention. The nature of targeted approach, full use local
knowledge and resources, and community participation, lead the integrated strategy
has lower costs and higher effectiveness, which could substantially increase the
sustainability of rolling back malaria with fewer adverse ecology effects. It's also
more preferable because of creating a much malaria-safer macro-environment with
less restriction of human activities.
5.3 Choice
To effectively choose malaria prevention methods, local health policy-makers should
adapt malaria prevention knowledge both quantitatively (CEAs) and qualitatively (the
pros and cons of malaria prevention interventions) at a local level, especially the local
malaria epidemiological conditions, demographic factors, vector entomology and
insecticide and drug resistance conditions. And, also the incremental costs, and
therefore, cost-effectiveness, are affected by the degree of existing infrastructure. It
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would be more cost-effective to direct resources to areas in which there is existing
malaria control knowledge, skills and teams, such as existing residual house spraying
teams, existing knowledge base of environmental management, existing village health
worker teams or good coverage of nets, which are likely better-off areas.
Also one common issue reflected in CEAs to all malaria prevention interventions is
compliance rate. Chemoprophylaxis for infants requires mothers cooperating with
health village workers at home weekly or biweekly; RHS requires people not refusing
spraying team and not painting the sprayed wall before the end of transmission
season; environmental management requires community participations; and ITNs
needs very active community involvement. The comprehensive education
programmes, through which the compliance rate of most interventions could be well





This dissertation overall objective was to review cost-effectiveness analyses of
malaria prevention published from 1999 up to the middle of 2003, in the African
context. The specific aims were:
.:. To outline the extent of malaria in suthern Africa, its social and economic
costs, to list the alternative preventive measures and current malaria control
strategy
.:. To explain cost-effectiveness analysis (CEA) as a method of deciding between
alternative means of preventing malaria
.:. To review a large number of studies of preventive method to deal with
malaria, using a CEA framework, in order to show what methods are most cost
effective
6.2 An Overview of Results
Malaria is a high priority for African health policy-makers, who are faced with
complex dilemmas over the design of prevention strategies, the selection of
interventions to improve treatment, and the allocation of resources between malaria
control and other health care problems. When considered in conjunction with
information on affordability and feasibility, evidence from economic evaluations can
assist policy-makers in identifying interventions representing the best value for
money.
Available CEA studies provide some guidance to decision-makers. According to the
guideline that any intervention with a cost per DALY below US$ 150 is an attractive
use of resources, in low-income country (WHO, 1996), that all the malaria prevention
measures assessed would be cost-effective ways to bring down malaria morbidity and
mortality. The current CEAs review of malaria prevention covered interventions of
ITNs, RHS, chemoprophylaxis for infants and environmental management. For
infants, ITNs provided cost per death averted ranged from US$ 2019 (Kenya 1)-
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US$2879 (Tanzania) and cost per DALY US$ 111 (Tanzania); chemoprophylaxis
provided cost per DALY US$ 4.1 (Gonzalez et aI, 2000) and cost per DALY of
chemoprophylaxis plus iron US$ 5.0. For child, ITNs gave cost per DA US$ 1559
(Tanzania), cost per DALY US$ 57 (Tanzania) and cost per sick child averted US$ 61
(Kenya 1). For non-specific age-group, ITNs gave cost per infection averted US$ 29,
and RHS US$ 9 (see chapter 4 and section 5.1.1).
Besides the difficulties of comparability of CEAs in concerning to comparable range
of costs and effects, similar methodology, common effectiveness measures and
various geographic settings, from current CEA review of malaria prevention, the
review of Goodman et al (1999a) and the modelling study of Goodman et al (1999b),
in general, chemoprophylaxis for malaria prevention is the least expensive among
most cost-effective measures, followed by RHS I round a year, RHS 2 rounds a year,
ITNs with net treatment only and ITNs with net provision and treatment. The cost-
effectiveness of EM appears more expensive than ITNs with net treatment only and
less expensive than ITNs with net provision and treatment. Using different delivery
mechanisms for ITN programmes, socio-marketing approach appears more expensive
than the public delivery system (see section 5.1.1 and 5.1.2).
With regard to cost-effectiveness analyses of malaria prevention, the current policy
debates are limited by gross lack of information on the costs and effects of many
interventions, the very small number of CEAs available, the problems in generalizing
or comparing studies that relate to specific settings and use different methodologies
and outcome measures, and the lack of evidence on the costs and effects of
integrated/packages of measures. With regard to CEAs covered by current review,
CEA of environmental management was the first study of the kind, and filled the gap
of existing CEA knowledge base of malaria prevention. However, with limited data of
costs and effects, the results estimated over-optimistic. And, the studies from socio-
marketing settings ofITN programmes didn't explore the net coverage rate, the
compliance rate and retreatment rate. Moreover, there is an urgent need to examine
the changing effectiveness of RHS with other insecticides instead of DDT, especially
in the places that used DDT before and is planning or switch to other insecticides. It is
vital that all future trials of interventions also include economic components
conforming to internationally accepted methodological standards, and that a much
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greater effort be made to assess costs and effectiveness of routine delivery of
interventions (see section 5.1.3).
Decision-making in concerning to malaria prevention is not only determined by
quantitative studies of CEAs, but also qualitative investigation regarding to the
application complexity of malaria interventions. Wide-use of malaria
chemoprophylaxis is not recommended, since it could substantially increase the
growth of drug resistance. Chemoprophylaxis is only promoted to be used by target
groups, such as pregnant women and travellers (see section 5.2.1).
There are four factor which could reduce the cost-effectiveness ofITN - the
compliance rate that related user inquiries, the management skills, the affordability
both for individuals and governments and the delayed children's immunity
acquisition. Further, the preference of the strategy is disbelieving because of the
restrictive malaria-safe space. The strategy could be used in malaria endemic areas.
The slow improvement of malaria situation and the burdensome process won't
damage the situation further (see section 5.2.2).
RHS is generally less expensive than ITN, and this is most important feature of
malaria prevention for most malarious African countries. It is more feasible for
spraying reacting prediction indicators warn of an imminent epidemic by a trained
spray team with spray pumps and insecticide than ITN reacting by maintaining large
stocks of nets and issuing them. With regard to operation, management and finance,
RHS is a simpler, faster and cheaper method for malaria prevention than ITN. The
strategy is important for malaria prevention in epidemic-prone areas and economic-
important areas, also creates bigger malaria-safe space for households in endemic
areas (see section 5.2.3).
The big debate concerning RHS is the toxicity to environment, especially when
concerned DDT. However, there are three important features of DDT: first, DDT is
the cheapest and most effective method for killing mosquitoes. Second, there is no
need to drop DDT from crop dusters on acres of farms; low-does use ofDDT indoors
is unlikely to cause any significant harm to the environment or people. Third, DDT
use for the last 6 decades in southern Africa has not been faced with development of
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resistance (http://www.malaria.org.zw/pubs/vectorl.pdf). Many countries rely on the
use of DDT for the control of malaria. When DDT-spraying stops, the number of
malaria cases frequently explodes. DDT now is permitted in limited use with the
requirement of detailed recording (see section 5.2.4).
Environmental management of malaria prevention relies on ecological principles and
firm knowledge of the vector's natural history and has fewer adverse environment
effects. The strategy appears cost-effective and is relatively easy to combine with
other malaria interventions (see section 5.2.5).
The combination of RHS and EM could substantial increase the sustainability of
rolling back malaria with fewer adverse ecology effects, and be the solution of wise
and effective use spraying by sharing the knowledge of malaria vector entomology.
The costs could be expected lower by the targeted approach and sharing knowledge,
the effectiveness could be expected sustainable higher - EM mainly target at kill
vector larval and RHS mainly target at kill vector adults (see section 5.2.5).
However, it is important to notice that to effectively fight malaria, there is no certain
agreed one approach that could apply for all geographical and demographical
varieties. Local health policy-makers should adapt these quantitative analyses of
CEAs and qualitative investigations of malaria epidemiology, vector entomology,
demography and insecticide and drug resistance at a local. And, also, incremental
costs, and therefore, cost-effectiveness, are affected by the degree of existing
infrastructure, knowledge and managerial skills. It would be more cost-effective to
direct resources to areas in which there is existing malaria control knowledge, skills
and teams, such as existing residual house spraying teams, existing knowledge base of
environmental management, existing village health worker teams and good coverage
of nets, which are likely better-off areas. Further, comprehensive education
programme is greatly related with compliance rate in almost all malaria interventions,
therefore, should not be neglected (see section 5. 3).
73
Appendices




Annual economic cost of ITN programme
Effects (per year)
Number of persons protected
Number of all-cause child deaths (I-llmonths old)
averted
Life-years gained (LYG)
Discounted life-years gained (DLYG) at 3%




Gross cost per person protected
Gross cost per all-cause child death averted
Gross cost per LYG
Gross cost per DLYG at 3%
Gross cost per all-cause sick child visit averted
Gross cost per ITN














Appendix 2 Kenya 1 Gross outcomes with retreatment once a year
Costs
Annual economic cost of ITN programme
Net annual cost with community effect
Reduced annual economic cost ofITN
programme
Effects (per year)
Number of persons protected
Number of all-cause child deaths (l-I Imonths
old) averted
Life-years gained (LVG)
Discounted life-years gained (DLYG) at 3%




Gross cost per person protected
Gross cost per all-cause child death averted
Gross cost per LYG
Gross cost per DLYG at 3%
Gross cost per all-cause sick child visit averted
Gross cost per ITN
*Net economic costs (including community
















* The information is from sensitivity study of retreatment once a year of the study
** Recalculated from the result of the item of reduced annual economic cost ofITN
programme
Appendix 3 Cost-effectiveness ratios of KINET for infants (US$ in 2000 price)
Reference
Costs (1-11 months)
Total cost 149682 Hanson et aI., Table 3
Effects (1-11 months)
No. of death averted 52 Hanson et aI., Table 5
No. ofDALYs averted 1347.1 Hanson et aI., Table 5
Cost-effectiveness ratios
Cost per DA 2879
Cost per DALY III
Appendix 4 ITN retreatment rate of Tanzania study
Reference




Treated-net year from nets and
retreatment kit sold
No. of re-treated-net years needed
Retreatment rate
65111
4 (Jul 1996 - lun 2000)
24393
*44752
65111 *3 = 195333
*(44752 - 6511112)1195333 = 6.3%
Hanson et aI., p272
Hanson et aI, p 270&272
Hanson et aI., p272
Hanson et aI, p272
* The retreatment should be biannually (65111 +24393)/2 = 44752.
Appendix 5 Gross cost-effectiveness ratios of chemoprophylaxis and chemoprophylaxis
+ iron for malaria prevention (in US$, 1996 value)
Number of children provided by malaria intervention
Deltaprim + iron
Total cost for health care 16998
provider
Cost per child for health 7.3
care provider
Number of children 2329
provided by interventions







Gonzalez et al 2000, table 2.












6424 Gonzalez et al 2000, table 2.
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